WisdomTree 10Q 2023 Q2 Quarterly report

WisdomTree (WT) 10-Q2023 Q2 Quarterly report

Content analysis

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form

10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission File Number

001-10932

WisdomTree, Inc.

(Exact name of registrant as specified in its charter)


Delaware		13-3487784
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

250 West 34 th Street 3 rd Floor New York, New York		10119
(Address of principal executive offices)		(Zip Code)

212-801-2080

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value Preferred Stock Purchase Rights	WT	The New York Stock Exchange The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule

12b-2

of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☐ No ☒

As of August 2, 2023, there were 150,324,501 shares of the registrant’s Common Stock, $0.01 par value per share, outstanding.

Table of Contents

WISDOMTREE, INC.

Form

10-Q

For the Quarterly Period Ended June 30, 2023

TABLE OF CONTENTS


PART I: FINANCIAL INFORMATION		4

ITEM 1.	FINANCIAL STATEMENTS	4

ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	37

ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	57

ITEM 4.	CONTROLS AND PROCEDURES	58

PART II: OTHER INFORMATION		59

ITEM 1.	LEGAL PROCEEDINGS	59

ITEM 1A.	RISK FACTORS	59

ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	59

ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	59

ITEM 4.	MINE SAFETY DISCLOSURES	59

ITEM 5.	OTHER INFORMATION	60

ITEM 6.	EXHIBITS	61

Unless otherwise indicated, references to “the Company,” “we,” “us,” “our” and “WisdomTree” mean WisdomTree, Inc. and its subsidiaries.

WisdomTree

, WisdomTree Prime

™

and Modern Alpha

are trademarks of WisdomTree, Inc. in the United States and in other countries. All other trademarks are the property of their respective owners.

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form

10-Q,

or Report, contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect our results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in the section entitled “Risk Factors” included in our Annual Report on Form

10-K

for the fiscal year ended December 31, 2022. If one or more of these or other risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Report and the documents that we reference in this Report and have filed with the Securities and Exchange Commission, or the SEC, as exhibits to this Report, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.

In particular, forward-looking statements in this Report may include statements about:

•

anticipated trends, conditions and investor sentiment in the global markets and exchange-traded products, or ETPs;

•

anticipated levels of inflows into and outflows out of our ETPs;

•

our ability to deliver favorable rates of return to investors;

•

competition in our business;

•

whether we will experience future growth;

•

our ability to develop new products and services and their potential for success;

•

our ability to maintain current vendors or find new vendors to provide services to us at favorable costs;

•

our ability to successfully implement our strategy relating to digital assets and blockchain-enabled financial services, including WisdomTree Prime

™

, and achieve its objectives;

•

our ability to successfully operate and expand our business in

non-U.S.

markets;

•

the effect of laws and regulations that apply to our business; and

•

actions of activist stockholders.

The forward-looking statements in this Report represent our views as of the date of this Report. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Therefore, these forward-looking statements do not represent our views as of any date other than the date of this Report.

Table of Contents

PART I: FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

WisdomTree, Inc. and Subsidiaries

Consolidated Balance Sheets

(In Thousands, Except Per Share Amounts)


	June 30, 2023		December 31, 2022
Assets	(unaudited)
Current assets:


Cash and cash equivalents (Note 3)	$	83,735	$	132,101
Financial instruments owned, at fair value (including $38,451 and $25,283 invested in WisdomTree products at June 30, 2023 and December 31, 2022, respectively) (Note 5)		65,492		126,239
Accounts receivable (including $32,642 and $24,139 due from related parties at June 30, 2023 and December 31, 2022, respectively)		34,208		30,549
Prepaid expenses		8,161		4,684
Income taxes receivable		894		—
Other current assets		376		390

Total current assets		192,866		293,963
Fixed assets, net		487		544
Indemnification receivable (Note 20)		—		1,353
Securities held-to-maturity		245		259
Deferred tax assets, net (Note 20)		7,626		10,536
Investments (Note 7)		40,002		35,721
Right of use assets—operating leases (Note 12)		849		1,449
Goodwill (Note 22)		86,841		85,856
Intangible assets, net (Note 22)		604,407		603,567
Other noncurrent assets		454		571

Total assets	$	933,777	$	1,033,819

Liabilities and stockholders’ equity
Liabilities
Current liabilities:
Fund management and administration payable	$	30,635	$	36,521
Compensation and benefits payable		17,800		24,121
Operating lease liabilities (Note 12)		849		1,125
Convertible notes—current (Note 10)		—		59,197
Deferred consideration—gold payments (Note 9)		—		16,796
Income taxes payable		—		1,599
Accounts payable and other liabilities		18,997		9,075

Total current liabilities		68,281		148,434
Convertible notes (Note 10)		274,140		262,019
Deferred consideration—gold payments (Note 9)		—		183,494
Operating lease liabilities (Note 12)		—		339
Other noncurrent liabilities (Note 20)		—		1,353

Total liabilities		342,421		595,639

Preferred stock—Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $103,480 and $77,969 at June 30, 2023 and December 31, 2022, respectively) (Note 11)		132,569		132,569

Contingencies (Note 13)
Stockholders’ equity
Preferred stock, par value $0.01; 2,000 shares authorized		—		—
Preferred stock—Series C Non-Voting Convertible, par value $0.01; 13.087 shares authorized, issued and outstanding		—		—
Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 150,343 and 146,517 at June 30, 2023 and December 31, 2022, respectively		1,503		1,465
Additional paid-in capital		383,621		291,847
Accumulated other comprehensive loss		(693)		(1,420)
Retained earnings		74,356		13,719

Total stockholders’ equity		458,787		305,611

Total liabilities and stockholders’ equity	$	933,777	$	1,033,819

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Operating Revenues:



Advisory fees	$	82,004	$	75,586	$	159,641	$	152,103
Other income		3,720		1,667		8,127		3,518

Total revenues		85,724		77,253		167,768		155,621

Operating Expenses:
Compensation and benefits		26,319		24,565		53,717		49,352
Fund management and administration		17,727		16,076		34,880		31,570
Marketing and advertising		4,465		3,894		8,472		7,917
Sales and business development		3,326		3,131		6,320		5,740
Contractual gold payments (Note 9)		1,583		4,446		6,069		8,896
Professional fees		8,334		4,308		12,049		8,767
Occupancy, communications and equipment		1,172		1,049		2,273		1,802
Depreciation and amortization		121		53		230		100
Third-party distribution fees		1,881		1,818		4,134		4,030
Other		2,615		2,109		4,872		3,954

Total operating expenses		67,543		61,449		133,016		122,128

Operating income		18,181		15,804		34,752		33,493
Other Income/(Expenses):
Interest expense		(4,021)		(3,733)		(8,023)		(7,465)
Gain/(loss) on revaluation/termination of deferred consideration—gold payments (Note 9)		41,361		2,311		61,953		(14,707)
Interest income		1,000		770		2,083		1,564
Impairments (Note 7)		—		—		(4,900)		—
Loss on extinguishment of convertible notes (Note 10)		—		—		(9,721)		—
Other gains and losses, net		1,286		(4,474)		(721)		(29,181)

Income/(loss) before income taxes		57,807		10,678		75,423		(16,296)
Income tax expense/(benefit)		3,555		2,673		4,938		(14,040)

Net income/(loss)	$	54,252	$	8,005	$	70,485	$	(2,256)

Earnings/(loss) per share—basic	$	0.32	$	0.05	$	0.43	$	(0.02)

Earnings/(loss) per share—diluted	$	0.32	$	0.05	$	0.42	$	(0.02)

Weighted-average common shares—basic		144,351		143,046		144,108		142,915

Weighted-average common shares—diluted		170,672		158,976		165,468		142,915

Cash dividends declared per common share	$	0.03	$	0.03	$	0.06	$	0.06

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income/(Loss)

(In Thousands)

(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net income/(loss)	$	54,252	$	8,005	$	70,485	$	(2,256)
Other comprehensive income/(loss)
Foreign currency translation adjustment, net of income taxes		261		(1,721)		727		(2,207)

Other comprehensive income/(loss)		261		(1,721)		727		(2,207)

Comprehensive income/(loss)	$	54,513	$	6,284	$	71,212	$	(4,463)

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Equity

(In Thousands)

(Unaudited)


	For the Three Months Ended June 30, 2023
	Series C Preferred Stock				Common Stock				Additional Paid-In Capital		Accumulated Other Comprehensive Loss		Retained Earnings		Total
	Shares Issued		Par Value		Shares Issued		Par Value		Additional Paid-In Capital		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance—April 1, 2023		—	$	—		149,291	$	1,493	$	292,971	$	(954)	$	25,028	$	318,538
Shares issued in connection with termination of the deferred consideration—gold payments obligation, net of issuance costs (Note 9)		13		—		—		—		86,801		—		—		86,801
Restricted stock issued and vesting of restricted stock units, net		—		—		41		—		—		—		—		—
Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10)		—		—		1,037		10		35		—		—		45
Shares repurchased		—		—		(26)		—		(156)		—		—		(156)
Stock-based compensation		—		—		—		—		3,970		—		—		3,970
Other comprehensive income		—		—		—		—		—		261		—		261
Dividends		—		—		—		—		—		—		(4,924)		(4,924)
Net income		—		—		—		—		—		—		54,252		54,252

Balance—June 30, 2023		13	$	—		150,343	$	1,503	$	383,621	$	(693)	$	74,356	$	458,787


	For the Three Months Ended June 30, 2022
	Series C Preferred Stock				Common Stock				Additional Paid-In Capital		Accumulated Other Comprehensive Income/(Loss)		Accumulated Deficit		Total
	Shares Issued		Par Value		Shares Issued		Par Value		Additional Paid-In Capital		Accumulated Other Comprehensive Income/(Loss)		Accumulated Deficit		Total
Balance—April 1, 2022		—	$	—		146,560	$	1,466	$	284,421	$	196	$	(32,706)	$	253,377
Restricted stock issued and vesting of restricted stock units, net		—		—		(49)		(1)		1		—		—		—
Stock-based compensation		—		—		—		—		2,432		—		—		2,432
Other comprehensive loss		—		—		—		—		—		(1,721)		—		(1,721)
Dividends		—		—		—		—		(4,837)		—		—		(4,837)
Net income		—		—		—		—		—		—		8,005		8,005

Balance—June 30, 2022		—	$	—		146,511	$	1,465	$	282,017	$	(1,525)	$	(24,701)	$	257,256

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Equity (Continued)

(In Thousands)

(Unaudited)


	For the Six Months Ended June 30, 2023
	Series C Preferred Stock				Common Stock				Additional Paid-In Capital		Accumulated Other Comprehensive Loss		Retained Earnings		Total
	Shares Issued		Par Value		Shares Issued		Par Value		Additional Paid-In Capital		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance—January 1, 2023		—	$	—		146,517	$	1,465	$	291,847	$	(1,420)	$	13,719	$	305,611
Shares issued in connection with termination of the deferred consideration—gold payments obligation, net of issuance costs (Note 9)		13		—		—		—		86,801		—		—		86,801
Restricted stock issued and vesting of restricted stock units, net		—		—		3,420		34		(34)		—		—		—
Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10)		—		—		1,037		10		35		—		—		45
Shares repurchased		—		—		(631)		(6)		(3,534)		—		—		(3,540)
Stock-based compensation		—		—		—		—		8,506		—		—		8,506
Other comprehensive income		—		—		—		—		—		727		—		727
Dividends		—		—		—		—		—		—		(9,848)		(9,848)
Net income		—		—		—		—		—		—		70,485		70,485

Balance—June 30, 2023		13	$	—		150,343	$	1,503	$	383,621	$	(693)	$	74,356	$	458,787


	For the Six Months Ended June 30, 2022
	Series C Preferred Stock				Common Stock				Additional Paid-In Capital		Accumulated Other Comprehensive Income/(Loss)		Accumulated Deficit		Total
	Shares Issued		Par Value		Shares Issued		Par Value		Additional Paid-In Capital		Accumulated Other Comprehensive Income/(Loss)		Accumulated Deficit		Total
Balance—January 1, 2022		—	$	—		145,107	$	1,451	$	289,736	$	682	$	(22,445)	$	269,424
Restricted stock issued and vesting of restricted stock units, net		—		—		1,993		20		(20)		—		—		—
Shares repurchased		—		—		(589)		(6)		(3,388)		—		—		(3,394)
Stock-based compensation		—		—		—		—		5,368		—		—		5,368
Other comprehensive loss		—		—		—		—		—		(2,207)		—		(2,207)
Dividends		—		—		—		—		(9,679)		—		—		(9,679)
Net income		—		—		—		—		—		—		(2,256)		(2,256)

Balance—June 30, 2022		—	$	—		146,511	$	1,465	$	282,017	$	(1,525)	$	(24,701)	$	257,256

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(In Thousands)

(Unaudited)


	Six Months Ended June 30,
	2023		2022

Cash flows from operating activities:
Net income/(loss)	$	70,485	$	(2,256)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
(Gain)/loss on revaluation/termination of deferred consideration—gold payments		(61,953)		14,707
Advisory and license fees paid in gold, other precious metals and cryptocurrency		(25,692)		(31,511)
Loss on extinguishment of convertible notes		9,721		—
Stock-based compensation		8,506		5,368
Contractual gold payments		6,069		8,896
Impairments		4,900		—
Deferred income taxes		2,964		3,378
Amortization of issuance costs—convertible notes		1,069		1,293
(Gains)/losses on financial instruments owned, at fair value		(947)		9,322
Losses on investments		819		—
Amortization of right of use asset		640		332
Depreciation and amortization		230		100
Other		—		120
Changes in operating assets and liabilities:
Accounts receivable		(5,254)		(3,718)
Prepaid expenses		(3,425)		(3,613)
Gold and other precious metals		18,441		23,743
Other assets		347		(241)
Intangibles—software development		(946)		(724)
Fund management and administration payable		6,419		423
Compensation and benefits payable		(18,941)		(13,537)
Income taxes payable		(2,523)		(5,235)
Operating lease liabilities		(652)		(348)
Accounts payable and other liabilities		9,752		2,043

Net cash provided by operating activities		20,029		8,542

Cash flows from investing activities:
Purchase of financial instruments owned, at fair value		(40,532)		(32,488)
Purchase of investments		(10,000)		(11,863)
Acquisition of Securrency Transfers, Inc. (net of cash acquired)		(985)		—
Purchase of fixed assets		(58)		(205)
Proceeds from the sale of financial instruments owned, at fair value		102,020		21,455
Receipt of contingent consideration – Sale of Canadian ETF business		1,477		—
Proceeds from held-to-maturity securities maturing or called prior to maturity		14		31

Net cash provided by/(used in) investing activities		51,936		(23,070)

Cash flows from financing activities:
Repurchase and maturity of convertible notes (Note 10)		(184,272)		—
Termination of deferred consideration—gold payments		(50,005)		—
Dividends paid		(9,647)		(9,679)
Issuance costs—Convertible notes		(3,548)		—
Shares repurchased		(3,540)		(3,394)
Issuance costs—Series C Preferred Stock		(97)		—
Proceeds from the issuance of convertible notes (Note 10)		130,000		—

Net cash used in financing activities		(121,109)		(13,073)

Increase/(decrease) in cash flow due to changes in foreign exchange rate		778		(3,372)

Net decrease in cash and cash equivalents		(48,366)		(30,973)
Cash and cash equivalents—beginning of year		132,101		140,709

Cash and cash equivalents—end of period	$	83,735	$	109,736

Supplemental disclosure of cash flow information:
Cash paid for income taxes	$	5,900	$	7,724

Cash paid for interest	$	4,514	$	6,156

Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Cash Flows (Continued)

(In Thousands)

(Unaudited)

NON-CASH

INVESTING AND FINANCING ACTIVITIES

On May 10, 2023, the Company issued

13.087

shares of Series C Non-Voting Convertible Preferred Stock (valued at $

86,898) in connection with the termination of its deferred consideration—gold payments obligation. See Notes 9 and 11 for additional information.

On June

15, 2023, the Company issued 1,037 shares of common stock (as the conversion option was in the money) in connection with the maturity of $60,000 aggregate principal amount of 4.25% Convertible Senior Notes.

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

WisdomTree, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(In Thousands, Except Share and Per Share Amounts)

1. Organization and Description of Business

WisdomTree, Inc., through its global subsidiaries (collectively, “WisdomTree” or the “Company”), is a global financial innovator, offering a well-diversified suite of exchange-traded products (“ETPs”), models and solutions. Building on its heritage of innovation, the Company is also developing and has recently launched next-generation digital products and structures, including digital or blockchain-enabled mutual funds (“Digital Funds”) and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime

™

. The Company has the following wholly-owned operating subsidiaries:

•

WisdomTree Asset Management, Inc.

is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (“WTT”) and WisdomTree exchange-traded funds (“ETFs”). The WisdomTree ETFs are issued in the U.S. by WTT. WTT is a

non-consolidated

Delaware statutory trust registered with the SEC as an

open-end

management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.

•

WisdomTree Management Jersey Limited

(“ManJer”) is a Jersey based management company providing management services to seven issuers (the “ManJer Issuers”) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and

leveraged-and-inverse

strategies.

•

WisdomTree Multi Asset Management Limited

(“WTMAML”) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (“WMAI”) in respect of the ETPs issued by WMAI. WMAI is a

non-consolidated

public limited company domiciled in Ireland.

•

WisdomTree Management Limited

(“WML”) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (“WTICAV”) in respect of the WisdomTree UCITS ETFs issued by WTICAV. WTICAV is a

non-consolidated

public limited company domiciled in Ireland.

•

WisdomTree UK Limited

(“WTUK”) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.

•

WisdomTree Europe Limited

is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK. WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.

•

WisdomTree Ireland Limited

is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.

•

WisdomTree Digital Commodity Services, LLC

is a New York based company that has been formed to serve as the sponsor of the WisdomTree Bitcoin Trust and WisdomTree Ethereum Trust, each an ETF currently under review with the SEC.

•

WisdomTree Digital Management, Inc.

(“WT Digital Management”) is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (“WTDT”) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S. by WTDT. WTDT is a

non-consolidated

Delaware statutory trust registered with the SEC as an

open-end

management investment company. Each Digital Fund uses blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but does not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies.

•

WisdomTree Digital Movement, Inc

. is a New York based company operating as a money services business registered with the Financial Crimes Enforcement Network and seeking state money transmitter licenses to operate a platform for the purchase, sale and exchange of digital assets, while also providing digital wallet services through WisdomTree Prime

™

to facilitate such activity.

•

WisdomTree Securities, Inc

. is a New York based limited purpose broker-dealer (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.

•

WisdomTree Transfers, Inc.

is a New York based transfer agent registered with the SEC, providing transfer agency services for the Digital Funds. The transfer agent maintains the official record of share ownership in book entry form and reconciles the official record with the secondary record of ownership of shares on one or more blockchains.

Table of Contents

2. Significant Accounting Policies

Basis of Presentation

These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Consolidation

The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.

Segment and Geographic Information

The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.

Foreign Currency Translation

Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.

Revenue Recognition

The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Contractual Gold Payments

Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9). The Company’s obligation to continue making these payments terminated on May 10, 2023.

Marketing and Advertising

Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.

Depreciation and Amortization

Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:


Equipment			3 to 5 years
Internally-developed software			3 years

The assets listed above are recorded at cost less accumulated depreciation and amortization.

Table of Contents

Stock-Based Awards

Accounting

for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.

Third-Party Distribution Fees

The

Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred.

Cash and Cash Equivalents

The

Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.

Accounts Receivable

Accounts

receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.

Impairment of Long-Lived Assets

The

Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.

Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)

Financial

instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or

available-for-sale

(“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.

Securities

Held-to-Maturity

The

Company accounts for certain of its securities as

held-to-maturity

on a trade date basis, which are recorded at amortized cost. For

held-to-maturity

securities, the Company has the intent and ability to hold these securities to maturity and it is not

more-likely-than-not

that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity.

Held-to-maturity

securities are placed on

non-accrual

status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on

held-to-maturity

securities placed on

non-accrual

status is recognized on a cash basis as interest income if and when received.

The

Company reviews its portfolio of

held-to-maturity

securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.

Investments

in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.

Table of Contents

Investments

The

Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321,

Investments – Equity Securities

(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.

Investments

in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).

Goodwill

is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring

re-evaluation,

if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

Goodwill

is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.

Goodwill

is assessed for impairment annually on November 30

. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.

Intangible Assets

Indefinit

e-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values.

Finit

e-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.

The

Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30

Software Development Costs

Software

development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.

Leases

The

Company accounts for its lease obligations in accordance with ASC Topic 842,

Leases

(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting

right-of-use

asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement,

right-of-use

assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term.

ASC

842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and

non-lease

components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.

Table of Contents

Deferred Consideration—Gold Payments

Deferred

consideration—gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation were reported as gain/(loss) on revaluation/termination of deferred consideration—gold payments in the Consolidated Statements of Operations.

Convertible Notes

Convertible

notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.

Contingencies

The

Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.

Contingent Payments

The

Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.

Earnings per Share

Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A

non-voting

convertible preferred stock and Series C

non-voting

convertible preferred stock (Note 11) and unvested stock-based equity awards that contain

non-forfeitable

rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the

two-class

method. Stock-based equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).

Diluted

EPS is calculated under the treasury stock method and the

two-class

method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A

non-voting

convertible preferred stock, the Series C

non-voting

convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A

non-voting

convertible preferred stock, the Series C

non-voting

convertible preferred stock and the convertible notes are computed under the

if-converted

method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price.

Income Taxes

The

Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is

more-likely-than-not

that some portion or all the deferred tax assets will not be realized.

Tax

positions are evaluated utilizing a

two-step

process. The Company first determines whether any of its tax positions are

more-likely-than-not

to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.

The

Global Intangible

Low-Taxed

Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.

Non-income

based taxes are recorded as part of other liabilities and other expenses.

Table of Contents

3. Cash and Cash Equivalents

the total cash and cash equivalents of $83,735 and $132,101 at June 30, 2023 and December 31, 2022, $82,683 and $131,104, respectively, were held at two financial institutions. At June 30, 2023 and December 31, 2022, cash equivalents were approximately $195 and $930, respectively.

Certain

of the Company’s subsidiaries are required to maintain a minimum level of regulatory capital, which was $24,912 and $25,988 at June 30, 2023 and December 31, 2022, respectively. These requirements are generally satisfied by cash on hand.

4. Fair Value Measurements

The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. ASC 820,

Fair Value Measurement

, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3 – Instruments whose significant drivers are unobservable.

The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three and six months ended June 30, 2023 and 2022, there were no transfers between Levels 2 and 3.


	June 30, 2023
	Total		Level 1		Level 2		Level 3
Assets:
Recurring fair value measurements:
Cash equivalents	$	195	$	195	$	—	$	—
Financial instruments owned, at fair value:
ETFs		26,509		26,509		—		—
Pass-through GSEs		26,107		—		26,107		—
Other assets—seed capital (WisdomTree Digital Funds):
U.S. treasuries		4,794		4,794		—		—
Equities		5,514		5,514		—		—
Fixed income		1,908		—		1,908		—
Other		660		—		660		—
Investments in Convertible Notes (Note 7):
Securrency, Inc.—convertible note		13,836		—		—		13,836
Securrency, Inc.—secured convertible note		8,887		—		—		8,887
Fnality International Limited—convertible note		7,879		—		—		7,879

Total	$	96,289	$	37,012	$	28,675	$	30,602

Table of Contents


	June 30, 2023
	Total		Level 1		Level 2		Level 3
Non-recurring fair value measurements:
Securrency, Inc.—Series A convertible preferred stock (1)	$	3,588	$	—	$	—	$	3,588

(1)	Fair value determined on March 31, 2023.


	December 31, 2022
	Total		Level 1		Level 2		Level 3
Assets:
Recurring fair value measurements:

Cash equivalents	$	930	$	930	$	—	$	—
Financial instruments owned, at fair value
ETFs		23,772		23,772		—		—
U.S. treasuries		2,980		2,980		—		—
Pass-through GSEs		96,837		23,290		73,547		—
Corporate bonds		885		—		885		—
Other assets—seed capital (WisdomTree Digital Funds)		1,765		—		1,765		—
Investments in Convertible Notes (Note 7)
Securrency, Inc.—convertible note		14,500		—		—		14,500
Fnality International Limited—convertible note		6,921		—		—		6,921

Total	$	148,590	$	50,972	$	76,197	$	21,421

Non-recurring fair value measurements:
Other investments (1)	$	312	$	—	$	—	$	312

Liabilities:
Recurring fair value measurements:
Deferred consideration—gold payments (Note 9)	$	200,290	$	—	$	—	$	200,290

(1)	Fair value determined on May 10, 2022.

Recurring Fair Value Measurements – Methodology

Cash Equivalents (Note 3)

– These financial assets represent cash invested in highly liquid investments with original maturities of less than 90 days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.

Financial instruments owned (Note 5)

– Financial instruments owned are investments in ETFs, U.S. treasuries, pass-through GSEs, equities, fixed income and other assets. ETFs, U.S. treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass-through GSEs, corporate bonds and fixed income include consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level 2. Pass-through GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.

Table of Contents

Fair Value Measurements classified as Level

– The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Investments in Convertible Notes (Note 7)
Beginning balance	$	17,502	$	6,700	$	21,421	$	—
Purchases		10,000		5,000		10,000		11,863
Net unrealized gains/(losses) ( 1)		3,100		12		(819)		(151)

Ending balance	$	30,602	$	11,712	$	30,602	$	11,712

Deferred Consideration (Note 9)
Beginning balance	$	179,831	$	245,177	$	200,290	$	228,062
Net realized losses (2)		1,583		4,446		6,069		8,896
Net unrealized (gains)/losses (3)		(41,361)		(2,311)		(61,953)		14,707
Settlements		(140,053)		(4,545)		(144,406)		(8,898)

Ending balance	$	—	$	242,767	$	—	$	242,767

(1)	Recorded in other gains and losses, net in the Consolidated Statements of Operations.

(2)	Recorded as contractual gold payments expense in the Consolidated Statements of Operations.

(3)

Recorded as gain/(loss) on revaluation/termination of deferred consideration—gold payments in the Consolidated Statements of Operati

5. Financial instruments owned

These instruments consist of the following:


	June 30, 2023		December 31, 2022
Financial instruments owned
Trading securities	$	52,616	$	124,474	��
Other assets—seed capital (WisdomTree Digital Funds)		12,876		1,765

	$	65,492	$	126,239

The Company

recognized net trading (losses)/gains on financial instruments owned that were still held at the reporting dates of ($222) and ($3,596) during the three months ended June 30, 2023 and 2022, respectively, and $1,309 and ($7,912) during the six months ended June 30, 2023 and 2022, respectively, which were recorded in other gains and losses, net, in the Consolidated Statements of Operations.

6. Securities

Held-to-Maturity

The following table is a summary of the Company’s securities

held-to-maturity:


	June 30, 2023		December 31, 2022
Debt instruments: Pass-through GSEs (amortized cost)	$	245	$	259

During

the six months ended June 30, 2023 and 2022, the Company received proceeds of $14 and $31, respectively, from

held-to-maturity

securities maturing or being called prior to maturity.

Table of Contents

The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities

held-to-maturity:


	June 30, 2023		December 31, 2022
Cost/amortized cost	$	245	$	259
Gross unrealized losses		(19)		(20)

Fair value	$	226	$	239

An allowance for credit losses was not provided on the Company’s

held-to-maturity

securities as all securities are investments in pass-through GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.

The following table sets forth the maturity profile of the securities

held-to-maturity;

however, these securities may be called prior to the maturity date:


	June 30, 2023		December 31, 2022
Due within one year	$	—	$	—
Due one year through five years		—		—
Due five years through ten years		24		27
Due over ten years		221		232

Total	$	245	$	259

7. Investments

The following table sets forth the Company’s investments:


	June 30, 2023				December 31, 2022
	Carrying Value		Cost		Carrying Value		Cost

Securrency, Inc.—Series A convertible preferred stock	$	3,588	$	8,112	$	8,488	$	8,112
Securrency, Inc.—Series B convertible preferred stock		5,500		5,500		5,500		5,500
Securrency, Inc.—secured convertible note		8,887		10,000		—		—
Securrency, Inc.—convertible note		13,836		15,000		14,500		15,000

Subtotal—Securrency, Inc.	$	31,811	$	38,612	$	28,488	$	28,612
Fnality International Limited—convertible note		7,879		6,863		6,921		6,863
Other investments		312		250		312		250

	$	40,002	$	45,725	$	35,721	$	35,725

Securrency, Inc. – Preferred Stock

The

Company owns approximately 22% (or 17% on a fully-diluted basis) of the capital stock of Securrency, Inc. (“Securrency”), a developer of institutional-grade blockchain-based financial and regulatory technology, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company received 5,178,488 shares of Series A convertible preferred stock (“Securrency Series A Shares”) in December 2019 and 2,004,665 shares of Series B convertible preferred stock (“Securrency Series B Shares”) in March 2021. The Securrency Series B Shares contain a liquidation preference that is pari passu with shares of Series

B-1

convertible preferred stock (which are substantially the same as the Securrency Series B Shares except that they have limited voting rights) and senior to that of the holders of the Securrency Series A Shares, which are senior to the holders of common stock. Otherwise, the Securrency Series A Shares and Securrency Series B Shares have substantially the same terms, are convertible into common stock at the option of the Company and contain various rights and protections including a

non-cumulative

6.0% dividend, payable if and when declared by the board of directors of Securrency. In addition, the Securrency Series A Shares and Securrency Series B Shares (together with the Securrency Series

B-1

convertible preferred stock) are separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at least 60% of the Securrency Series A Shares (at any time on or after December 31, 2029) and 90% of the Securrency Series B Shares (at any time on or after March 31, 2031).

The

se investments are accounted for under the measurement alternative prescribed in ASC 321, as they do not have a readily determinable fair value and are not considered to be

in-substance

common stock. The investments are assessed for impairment and similar observable transactions on a quarterly basis. There was

impairment recognized during the three months ended June 30, 2023 based upon a qualitative assessment. During the six months ended June 30, 2023, the Company recognized an impairment of $4,900

on its Securrency Series A Shares to reduce the carrying value of its investment to fair value. Fair value was determined using the probability-weighted expected return method (“PWERM”), a valuation approach that estimates fair value assuming various outcomes.

Table of Contents

The table below presents the probability ascribed to potential outcomes used in the PWERM, which resulted in the mark-down of the Securrency Series A Shares (classified as Level 3 in the fair value hierarchy). There was no mark-down applied to the Securrency Series B Shares, as they are a senior instrument.


	March 31, 2023

Conversion upon a future equity financing		33.3	%
Redemption upon a corporate transaction		33.3	%
Default		33.4	%

Ther

e was no impairment recognized during the three and six months ended June 30, 2022 based upon a qualitative assessment.

Securrency – Secured Convertible Note

In June 2023, the Company provided funding in the amount of $10,000,

and in consideration therefor, the Company was issued a

9% Secured Convertible Promissory Note maturing on December 31, 2023. The note is guaranteed by a U.S.-based wholly-owned subsidiary of Securrency and is secured by a valid and perfected first priority security interest in all existing and after acquired assets and personal property of the borrower, including all intellectual property and a pledge of

non-regulated

subsidiary equity.

The

note is convertible into Securrency’s preferred stock that is issued in the event of a qualified future equity financing of Securrency, subject to the Company’s right to require repayment, in whole or in part, to the extent such conversion would result in the Company obtaining a control position in Securrency. The note will convert at a conversion price equal to a discount of 25% to the price paid per share of preferred stock issued in such future equity financing round.

The

note is redeemable upon the occurrence of a corporate transaction for an amount which is the greater of (i) an amount equal to (x) 1.25 times (y) the sum of the principal amount and all accrued interest of the note (the “Liquidity Premium”) and (ii) such amount as would have been payable to the Company if the note had been converted, immediately prior to such corporate transaction, into that number of shares of the then most senior series of preferred stock of Securrency obtained by dividing (A) the Liquidity Premium by (B) the applicable conversion price, as set forth in the note. If not otherwise converted or redeemed, all unpaid interest accrued on the note and all (if any) other amounts payable on or in respect of the note or the indebtedness evidenced thereby owing to the Company will become immediately due and payable.

The

note is accounted for at fair value. Fair value is determined by the Company using the PWERM. During the three months ended June 30, 2023, the Company recognized an unrealized loss of $1,113 when

re-measuring

the note to fair value.

The

table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy).


		June 30, 2023
Conversion of note upon a future equity financing		50%
Redemption of note upon a corporate transaction		30%
Default		20%
Time to potential outcome (in years)		0.31

Securrency – Convertible Notes

April and November 2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in convertible notes of Securrency. In consideration for its investment, the Company was issued 7

% Convertible Promissory Notes maturing on

October 20, 2023.

The

notes are convertible into either common stock or a class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency’s common stock that is issued in the event of a qualified future equity financing of Securrency. The notes will convert at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.

The

notes are redeemable upon the occurrence of a corporate transaction for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted, in accordance with the terms of the notes, to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion may occur upon the election by the holders of a

majority-in-interest

of the aggregate principal amount of outstanding notes. If no such election is made, the Company may elect to convert the notes into common stock, in accordance with the terms of the notes, or require repayment of the aggregate principal and interest thereon.

Table of Contents

The

notes are accounted for at fair value. Fair value is determined by the Company using the PWERM. When

re-measuring

the notes to fair value, the Company recognized an unrealized gain of $3,785 during the three months ended June 30, 2023, and an unrealized loss of $664 during the six months ended June 30, 2023.

The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:




	June 30, 2023		December 31, 2022


Conversion of notes upon a future equity financing		50%		60%
Redemption of notes upon a corporate transaction		30%		25%
Default		20%		15%
Time to potential outcome (in years)		0.31		0.33

Fnality International Limited – Convertible Note

February 2022, the Company participated in a convertible note financing, making an investment of £5,000 ($6,863) in convertible notes of Fnality International Limited (“Fnality”), a company incorporated in England and Wales and focused on creating a

peer-to-peer

digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross-border payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December 31, 2023.

The

note is convertible into equity shares in the event of a future qualified equity financing of Fnality. The note will convert at a conversion price equal to the lower of (i) a discount of 20

% to the lowest price paid per equity share issued pursuant to such future financing round and (ii) an amount paid per share subject to a

pre-money

valuation cap. Mandatory conversion may occur on or after the maturity date or, if earlier, in the event a future financing round has not been completed within a specified time from an initial closing of such financing round (“Long Stop Date”), upon the approval of holders of at least

75% of the outstanding notes. The note is also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.

The

note is redeemable upon the occurrence of a change of control for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption may also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.

The

note is accounted for at fair value. Fair value is determined by the Company using the PWERM and is also remeasured for changes in the British pound and U.S. dollar exchange rate. During the three and six months ended June 30, 2023, the Company recognized a gain of $428 and $958, respectively, when

re-measuring

the notes to fair value.

The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:


	June 30, 2023		December 31, 2022




Conversion of note upon a future financing round		95%		85%
Redemption of note upon a change of control		0%		10%
Default		5%		5%
Time to potential outcome (in years)		0.08		0.25

8. Fixed Assets, net

The following table summarizes fixed assets:


	June 30, 2023		December 31, 2022
Equipment	$	1,037	$	962
Less: accumulated depreciation		(550)		(418)

Total	$	487	$	544

9. Deferred Consideration—Gold Payments

Deferred

consideration—gold payments represented an obligation the Company assumed in connection with its acquisition of the European exchange-traded commodity, currency and

leveraged-and-inverse

business of ETFS Capital Limited (“ETFS Capital”) which occurred on April 11, 2018. The obligation was for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and then subsequently reduced to 6,333

ounces of gold per year continuing into perpetuity (“contractual gold payments”). ETFS Capital continued to pass through the payments to other parties to meet its payment obligations under prior royalty agreements, including to Gold Bullion Holdings

Table of Contents

(Jersey) Limited (“GBH”), a subsidiary of the World Gold Council (“WGC”), Graham Tuckwell (“GT”), and Rodber Investments Limited (“RIL”), an entity controlled by GT, who is also the Chairman of ETFS Capital.

May 10, 2023, the Company terminated its contractual gold payments obligation for aggregate consideration totaling $136,903 pursuant to a Sale, Purchase and Assignment Deed (the “SPA Agreement”) with WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital, WGC, GBH, GT and RIL. Under the terms of the transaction, GBH received approximately $4,371 in cash and 13,087 shares of Series C

Non-Voting

Convertible Preferred Stock of the Company, $0.01

par value per share, convertible into

13,087,000 shares of the Company’s common stock, and RIL received approximately $45,634 in cash.

e Company determined the present value of the deferred consideration—gold payments of $0 and $200,290 at June 30, 2023 and December 31, 2022 using the following assumptions:


		June 30, 2023				December 31, 2022




Forward-looking gold price (low)—per ounce	n/a	$	1,858
Forward-looking gold price (high)—per ounce	n/a	$	3,126
Forward-looking gold price (weighted average)—per ounce	n/a	$	2,237
Discount rate	n/a		11.0%
Perpetual growth rate	n/a		1.3%

During the three and six months ended June 30, 2023 and 2022, the Company recognized the following in respect of deferred consideration—gold payments:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Contractual gold payments	$	1,583	$	4,446	$	6,069	$	8,896
Contractual gold payments—gold ounces paid		792		2,375		3167		4,750
Gain/(loss) on revaluation/termination of deferred consideration—gold payments	$	41,361	$	2,311	$	61,953	$	(14,707	)

10. Convertible Notes

February 14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between the Company and U.S. Bank Trust Company, National Association, as trustee (or its successor in interest, the “Trustee”), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”).

June 14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A.

June 16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, which constitute a further issuance of, and form a single series with, the Company’s June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”).

connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the six months ended June 30, 2023. The remainder of the 2020 Notes matured on June 15, 2023 and were settled for $59,955 in cash and 1,037,288 shares of common stock, as the conversion option was in the money.

After

the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (and together with the 2021 Notes, the “Convertible Notes”), the Company had $280,000 in aggregate principal amount of Convertible Notes outstanding.

Table of Contents

Key terms of the Convertible Notes are as follows:


	2023 Notes		2021 Notes



Principal outstanding		$130,000		$150,000
Maturity date (unless earlier converted, repurchased or redeemed)		August 15, 2028		June 15, 2026
Interest rate		5.75%		3.25%
Conversion price		$9.54		$11.04
Conversion rate		104.8658		90.5797
Redemption price		$12.40		$14.35

●

Interest rate:

Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and on June 15 and December 15 of each year for the 2021 Notes.

●

Conversion price:

Convertible at an initial conversion rate into shares of the Company’s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.

●

Conversion:

Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028 and March 15, 2026 for the 2023 Notes and 2021 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028 and March 15, 2026 in respect of the 2023 Notes and the 2021 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.

●

Cash settlement of principal amount:

Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.

●

Redemption price:

The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025 and June 20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55

scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.

●

Limited investor put rights:

Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.

●

Conversion rate increase in certain customary circumstances:

In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares and 144.9275 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of 43,551,214 shares of the Company’s common stock), subject to adjustment.

●

Seniority and Security:

The Convertible Notes rank equal in right of payment, and are the Company’s senior unsecured obligations, but are subordinated in right of payment to the Company’s obligations to make certain redemption payments (if and when due) in respect of its Series A

Non-Voting

Convertible Preferred Stock (Note 11).

The

indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than 25

% in aggregate principal amount of the respective series

Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.

Table of Contents

The

following table provides a summary of the Convertible Notes at June 30, 2023 and December 31, 2022:


	June 30, 2023									December 31, 2022
	2023 Notes			2021 Notes			Total			2021 Notes			2020 Notes			Total
Principal amount	$	130,000		$	150,000		$	280,000		$	150,000		$	175,000		$	325,000
Plus: Premium		—			—			—			—			250			250

Gross proceeds		130,000			150,000			280,000			150,000			175,250			325,250
Less: Unamortized issuance costs		(3,306	)		(2,554	)		(5,860	)		(2,981	)		(1,053	)		(4,034	)

Carrying amount		126,694		$	147,446		$	274,140		$	147,019		$	174,197		$	321,216

Effective interest rate (1)		6.25	%		3.83	%		4.96	%		3.83	%		5.26	%		4.60	%

(1)

Includes amortization of the issuance costs and premium.

Interest

expense on the Convertible Notes was $4,021 and $8,023 during the three and six months ended June 30, 2023 and $3,733 and $7,465, respectively, during the comparable periods in 2022. Interest payable of $3,061 and $621 at June 30, 2023 and December 31, 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.

The

fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $280,671 and $320,513 at June 30, 2023 and December 31, 2022, respectively. The

if-converted

value of the Convertible Notes did not exceed the principal amount at June 30, 2023 and December 31, 2022.

11. Preferred Stock

Series A

Non-Voting

Convertible Preferred Stock

April 10, 2018, the Company filed a Certificate of Designations of Series A

Non-Voting

Convertible Preferred Stock (the “Series A Certificate of Designations”) with the Delaware Secretary of State establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series A Preferred Stock (defined below). The Series A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company’s common stock on an

as-converted

basis. The Series A Preferred Stock has no voting rights, is not transferable and has the same priority with regard to dividends, distributions and payments as the common stock.

described in the Series A Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attributable parties) would beneficially own more than 9.99% of the Company’s outstanding common stock immediately after giving effect to such conversion.

connection with the completion of the acquisition of the European exchange-traded commodity, currency and

leveraged-and-inverse

business of ETFS Capital (the “ETFS Acquisition”), the Company issued 14,750 shares of Series A

Non-Voting

Convertible Preferred Stock (the “Series A Preferred Stock”), which are convertible into an aggregate of 14,750,000 shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company’s common stock on April 10, 2018 of $9.00 per share, the trading day prior to the closing of the acquisition.

The following is a summary of the Series A Preferred Stock balance:


	June 30, 2023		December 31, 2022
Issuance of Series A Preferred Stock	$	132,750	$	132,750
Less: Issuance costs		(181)		(181)

Series A Preferred Stock—carrying value	$	132,569	$	132,569

Cash dividends declared per share (quarterly)	$	0.03	$	0.03

Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company

Table of Contents

owes to any of its secured creditors or is otherwise prohibited by applicable law.

Any

such redemption will be at a price per Series A Preferred Stock equal to the dollar volume-weighted average price for a share of common stock for the

30-trading

day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by

1,000

. Such redemption payment will be made in one payment no later than

business days following the last day of the Company’s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series A Preferred Stock was $103,480 and $77,969 at June 30, 2023 and December 31, 2022, respectively.

The

carrying amount of the Series A Preferred Stock was not adjusted as it was not probable that the Series A Preferred Stock would become redeemable.

Series C

Non-Voting

Convertible Preferred Stock

May 10, 2023, the Company filed a Certificate of Designations of Series C

Non-Voting

Convertible Preferred Stock (the “Series C Certificate of Designations”) with the Delaware Secretary of State establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series C Preferred Stock (defined below). The Series C Preferred Stock is intended to provide GBH with economic rights equivalent to the Company’s common stock on an

as-converted

basis. The Series C Preferred Stock has no voting rights, is not transferable, contains registration rights and has the same priority with regard to dividends, distributions and payments as the common stock.

described in the Series C Certificate of Designations, the Company will not issue, and GBH does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series C Preferred Stock, if, as a result of such conversion, GBH (together with certain attributable parties) would beneficially own more than 4.99% of the Company’s outstanding common stock immediately after giving effect to such conversion. Further, as described in the Series C Certificate of Designations, the Company will not issue any shares of common stock upon conversion of the Series C Preferred Stock if the issuance would exceed the aggregate number of shares of common stock that the Company may issue without breaching its obligations under the rules of the New York Stock Exchange, unless the Company obtains stockholder approval for the issuance of the Company’s common stock upon conversion of the Series C Preferred Stock in excess of such amount.

Eac

h share of Series C Preferred Stock is convertible only in connection with the sale of all or any portion of the Company’s common stock on an arms-length basis to a bona fide third-party purchaser, pursuant to (i) an effective registration statement under the Securities Act of 1933, as amended (“Securities Act”) or (ii) an exemption from registration under the Securities Act, provided any such sale is conditioned on the terms set forth in the Investor Rights Agreement, dated May 10, 2023, between the Company and GBH.

Pursuant

to the Investor Rights Agreement, GBH is subject to restrictions on the manner in which the Conversion Shares (defined below) can be sold and has agreed not to distribute or sell any Conversion Shares to any person that would knowingly result in that person, together with such person’s affiliates and associates, owning, controlling or otherwise having any beneficial ownership interest representing in the aggregate 5% or more of the then outstanding shares of the Company’s common stock. GBH has also agreed not to distribute or sell any Conversion Shares to ETFS Capital, GT or any of their affiliates, associates or any Group (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as defined in Rule

13d-5

thereunder) formed by the foregoing persons.

accordance with the SPA Agreement, the Company issued 13,087 shares of Series C

Non-Voting

Convertible Preferred Stock (the “Series C Preferred Stock”), which are convertible into an aggregate of 13,087,000 shares of common stock (“Conversion Shares”). The fair value of this consideration was $86,898, based on the closing price of the Company’s common stock on May 9, 2023 of $6.64 per share, the trading day prior to the closing of the acquisition.

GBH

has no redemption rights associated with the Series C Preferred Stock and therefore the instrument has been classified as a component of stockholders’ equity, with the excess over par value of $86,801 (net of issuance costs of $97) recorded to additional paid in capital.

12. Leases

The

Company has entered into operating leases for its office facilities (including its corporate headquarters) and equipment. The Company has no finance leases.

Table of Contents

The following table provides additional information regarding the Company’s leases:


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Lease cost:
Operating lease cost	$	321		$	243		$	640		$	332
Short-term lease cost		65			251			121			527

Total lease cost	$	386		$	494		$	761		$	859

Other information:
Cash paid for amounts included in the measurement of operating liabilities (operating leases)	$	326		$	251		$	652		$	348

Right-of-use assets obtained in exchange for new operating lease liabilities		n/a			n/a			n/a			n/a

Weighted-average remaining lease term (in years)—operating leases		0.8			1.8			0.8			1.8

Weighted-average discount rate—operating leases		6.6	%		6.3	%		6.6	%		6.3	%

None of the Comp

ny’s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company’s ability to pay dividends or incur additional financing obligations.

The following table discloses future minimum lease payments at June 30, 2023 with respect to the Company’s operating lease liabilities:



Remainder of 2023	$	476
2024		397
2025 and thereafter		—

Total future minimum lease payments (undiscounted)	$	873

The following table reconciles the future minimum lease payments (disclosed above) at June 30, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets:





Amounts recognized in the Company’s Consolidated Balance Sheets
Lease liability—short term	$	849
Difference between undiscounted and discounted cash flows		24

Total future minimum lease payments (undiscounted)	$	873

13. Contingencies

The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.

Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP

In December 2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (“WT Ireland”) were served with a writ of summons to appear before the Court of Milan, Italy. In January 2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.

In February 2022, the Court of Udine ruled in the Company’s favor. Also in February 2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.

In March 2022, WMAI and WTUK were served with writs of summons to appear before the Court of Turin and the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. In July 2023, the Court of Milan ruled in favor of WMAI and WTUK in respect of one of these claims.

Total damages sought by all investors related to these claims are approximately €15,200 ($16,560) at June 30, 2023.

Table of Contents

Additionally, in July 2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately €

8,400 ($9,150)

resulting from the closure of 3OIL. The claim is in its preliminary stages and a writ of summons has not been served.

The Company is currently assessing these claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $

500

deductible. An accrual has not been made with respect to these matters at June 30, 2023 and December 31, 2022.

14. Variable Interest Entities

VIEs are entities with any of the following characteristics: (i) the entity does not have enough equity to finance its activities without additional financial support; (ii) the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii) the entity is structured with

non-substantive

voting rights.

Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities’ economic performance. Such power is conveyed through the entities’ boards of directors and the Company does not have control over the boards.

The following table presents information about the Company’s variable interests in

non-consolidated

VIEs:


	June 30, 2023		December 31, 2022
Carrying Amount—Assets (Securrency):

Preferred stock—Securrency Series A Shares	$	3,588	$	8,488
Preferred stock—Securrency Series B Shares		5,500		5,500
Secured convertible note		8,887		—
Convertible note		13,836		14,500

Subtotal—Securrency	$	31,811	$	28,488
Carrying Amount—Assets (Fnality):
Convertible note		7,879		6,921
Carrying Amount—Assets (Other investments):		312		312

Total (Note 7)	$	40,002	$	35,721

Maximum exposure to loss	$	40,002	$	35,721

15. Revenues from Contracts with Customers

The following table presents the Company’s total revenues from contracts with customers:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenues from contracts with customers:
Advisory fees	$	82,004	$	75,586	$	159,641	$	152,103
Other		3,720		1,667		8,127		3,518

Total operating revenues	$	85,724	$	77,253	$	167,768	$	155,621

The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity’s performance in transferring control of services to the customer.

Substantially all the Company’s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note 16). These advisory fees are recognized over time, are earned from the Company’s ETPs and are calculated based on a percentage of the ETPs’ average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Table of Contents

There

are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.

Other income includes revenues the Company earns from swap providers associated with certain of the Company’s European listed ETPs, the nature of which are either based on a percentage of the ETPs’ average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Geographic Distribution of Revenues

The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenues from contracts with customers:
United States	$	52,808	$	45,807	$	102,489	$	92,036
Jersey		29,158		27,811		58,211		56,409
Ireland		3,758		3,635		7,068		7,176

Total operating revenues	$	85,724	$	77,253	$	167,768	$	155,621

16. Related Party Transactions

Investment Advisory Agreements

The Company’s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S. WisdomTree ETFs, Digital Funds and WisdomTree UCITS ETFs. The Board of Trustees and Board of Directors (including certain officers of the Company) of the related parties are primarily responsible for overseeing the management and affairs of the entities for the benefit of their stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other

non-distribution

services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs’ and the Digital Funds’ average daily net assets. A majority of the independent members of the Board of Trustees are required to initially and annually (after the first two years) approve the advisory agreements of the U.S. WisdomTree ETFs and the Digital Funds and these agreements may be terminated by the Board of Trustees upon notice.

The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:


	June 30, 2023		December 31, 2022
Receivable from WTT	$	17,821	$	16,399
Receivable from ManJer Issuers		12,204		4,485
Receivable from WMAI and WTICAV		2,617		3,255

Total	$	32,642	$	24,139

The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30 days aged and are collected shortly after the applicable reporting period.

Table of Contents

The following table summarizes revenues from advisory services provided to related parties:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Advisory services provided to WTT	$	52,452	$	45,670	$	101,939	$	91,740
Advisory services provided to ManJer Issuers		25,794		26,282		50,634		53,187
Advisory services provided to WMAI and WTICAV		3,758		3,634		7,068		7,176

Total	$	82,004	$	75,586	$	159,641	$	152,103

Investments in WisdomTree Products

The

Company also has investments in certain WisdomTree products of approximately $38,451 and $25,283 at June 30, 2023 and December 31, 2022, respectively. This includes $12,876 and $1,765, respectively, of investments in certain consolidated affiliated Digital Funds advised by WT Digital Management, referred to herein as “other assets–seed capital.” Net unrealized and realized gains/(losses) related to trading WisdomTree products were $419 and $841, respectively, during the three and six months ended June 30, 2023 and ($313) and ($1,119), respectively, during the comparable periods in 2022. Such gains and losses are recorded in other gains and losses, net on the Consolidated Statements of Operations.

Deferred Consideration—Gold Payments – Termination

n May 10, 2023, the Company terminated its contractual gold payments obligation to ETFS Capital, which included the payment of $45,634 to an entity controlled by GT, a stockholder of the Company. See Note 9 for additional information.

17. Stock-Based Awards

July 15, 2022, the Company’s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000 shares of common stock (less one share for every share granted under the 2016 Equity Plan since June 30, 2022 and inclusive of shares available under the 2016 Equity Plan as of June 30, 2022) in the form of stock options and other stock-based awards.

The Company grants equity awards to employees and directors, which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions.

The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:

●

If the relative TSR is below the 25

percentile, then 0% of the target number of PRSUs granted will vest;

●

If the relative TSR is at the 25

percentile, then 50% of the target number of PRSUs granted will vest;

●

If the relative TSR is above the 25

percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50

percentile and capped at 200% of the target number of PRSUs granted for performance at the 85

percentile; and

●

If the Company’s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.

Stock

based compensation expense was $

3,970

and $

8,506

, respectively during the three and six months ended June 30, 2023 and $

2,432

and $

5,368

, respectively, during the comparable periods in 2022.

Table of Contents

A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:

	June 30, 2023
	Unrecognized Stock- Based Compensation		Weighted-Average Remaining Vesting Period (Years)
Employees and directors	$	27,110		1.87

A summary of stock-based compensation award activity (shares) during the three months ended June 30, 2023 is as follows:


	RSA			RSU			PRSU
Balance at April 1, 2023		5,154,289			188,748			1,136,315
Granted		78,410			78,410			—
Vested		(76,434	)		(19,762	)		—
Forfeited		(57,137	)		(19,762	)		—

Balance at June 30, 2023		5,099,128			227,634			1,136,315

18. Stockholder Rights Plan

On March 17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 17, 2023, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent, as amended by Amendment No. 1 thereto, dated May 4, 2023 (“Amendment No. 1”), and by Amendment No. 2 thereto, dated May 10, 2023 (“Amendment No. 2”) (as amended, the “Stockholder Rights Agreement”). At the Company’s 2023 Annual Meeting of Stockholders held on June 16, 2023, the Company’s stockholders ratified the adoption by the Board of Directors of the Stockholder Rights Agreement.

Pursuant to

the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i) one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company’s common stock and (ii) 1,000 Rights for each outstanding share of Series A Preferred Stock, to stockholders of record as of the close of business on March 28, 2023 (the “Record Date”). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each “Right” entitles the registered holder thereof to purchase from the Company a unit consisting of one

ten-thousandth

of a share (a “Unit”) of Series B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the “Series B Preferred Stock”) at a cash exercise price of $32.00 per Unit (the “Exercise Price”), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.

Initially, t

he Rights are not exercisable and are attached to and trade with all shares of common stock and Series A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series A Preferred Stock and will become exercisable upon the earlier of (i) the close of business on the tenth calendar day following the first public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule 13G pursuant to Rule

13d-1(b)

or Rule

13d-1(c)

of the General Rules and Regulations under the Exchange Act as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the “Stock Acquisition Date”), or (ii) the close of business on the tenth business day (or such later day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the “Distribution Date”). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company’s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.

For purposes

of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership. Pursuant to Amendment No. 1, beneficial ownership did not include the right to vote pursuant to any agreement, arrangement or understanding

with respect to voting on the proposal to approve and ratify the

Table of Contents

Stockholder Rights Agreement presented to the Company’s stockholders at the Company’s 2023 annual meeting of stockholders. Pursuant to Amendment No. 2, the parties to the SPA Agreement are not deemed to be “Acquiring Persons” solely by virtue of, or as a result of, the parties’ entry into the SPA Agreement, the issuance of the Series C Preferred Stock to GBH, and the performance or consummation of any of the other transactions contemplated by the SPA Agreement, among other conditions, under the terms and conditions set forth in Amendment No. 2.

In the even

t that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of Series B Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units of Series B Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the “Subscription Right”). In the event that, at any time following the Stock Acquisition Date, (i) the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii) any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii) 50% or more of the Company’s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the “Merger Right”). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.

The Rig

hts may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i) the time at which any person becomes an Acquiring Person or (ii) the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.

The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).

Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.

The Rights are not exercisable until the Distribution Date and will expire at the close of business on March 16, 2024, unless previously redeemed or exchanged by the Company.

The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a “Qualifying Offer” (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i) a fully financed

all-cash

tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii) an offer that is otherwise in the best interests of the Company’s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a “Qualifying Offer,” including if the consideration offered in a proposed transaction is stock of the acquiror.

Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board of Directors has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the “Special Meeting”) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90

business day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10

business day thereafter.

Table of Contents

19. Earnings/(Loss) Per Share

The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
Basic Earnings per Share	2023			2022			2023			2022
Net income/(loss)	$	54,252		$	8,005		$	70,485		$	(2,256	)
Less: Income distributed to participating securities		(496	)		(548	)		(994	)		(1,097	)
Less: Undistributed income allocable to participating securities		(7,046	)		(358	)		(7,583	)		—

Net income/(loss) available to common stockholders—Basic EPS	$	46,710		$	7,099		$	61,908		$	(3,353	)
Weighted average common shares (in thousands)		144,351			143,046			144,108			142,915

Basic earnings/(loss) per share	$	0.32		$	0.05		$	0.43		$	(0.02	)


	Three Months Ended June 30,						Six Months Ended June 30,
Diluted Earnings per Share	2023			2022			2023			2022
Net income/(loss) available to common stockholders	$	46,710		$	7,099		$	61,908		$	(3,353	)
Add back: Undistributed income allocable to participating securities		7,046			358			7,583			—
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive		(6,904	)		(357	)		(7,490	)		—

Net income/(loss) available to common stockholders—Diluted EPS	$	46,852		$	7,100		$	62,001		$	(3,353	)

Weighted Average Diluted Shares (in thousands):
Weighted average common shares		144,351			143,046			144,108			142,915
Dilutive effect of common stock equivalents, excluding participating securities		3,464			379			2,047			—

Weighted average diluted shares, excluding participating securities (in thousands)		147,815			143,425			146,155			142,915

Diluted earnings/(loss) per share	$	0.32		$	0.05		$	0.42		$	(0.02	)

Dilut

ed earnings/(loss) per share presented above is calculated using the

two-class

method as this method results in the lowest diluted earnings per share amount for common stock. During the six months ended June 30, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive

non-participating

common stock equivalents were

157

and

208

, respectively, during the three and six months ended June 30, 2023, and

303

and

300

, respectively, during the comparable periods in 2022 (shares herein are reported in thousands).

There

were 855 and 430 potential common shares associated with the conversion options embedded in the 2020 Notes included in weighted average diluted shares for the three and six months ended June 30, 2023. There were no such potential common shares for the comparable periods in 2022 as the Company’s average stock price was lower than the conversion price.

The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:


	Three Months Ended June 30,						Six Months Ended June 30,
Reconciliation of Weighted Average Diluted Shares (in thousands)	2023			2022			2023			2022
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations		170,672			158,976			165,468			142,915	(1)
Less: Participating securities
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)		(14,750	)		(14,750	)		(14,750	)		—
Weighted average shares of common stock issuable upon conversion of the Series C Preferred Stock (Note 11)		(7,478	)		—			(3,760	)		—
Potentially dilutive restricted stock awards		(629	)		(801	)		(803	)		—

Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above		147,815			143,425			146,155			142,915

(1)

Excludes 15,486 participating securities and 356 potentially dilutive

non-participating

common stock equivalents for the six months ended June 30, 2022 as the Company reported a net loss for the period (shares herein are reported in thousands).

Table of Contents

20. Income Taxes

Effective Income Tax Rate – Three and Six Months Ended June 30, 2

023

he Company’s effective income tax rate during the three months ended June 30, 2023 was 6.1%, resulting in income tax expense of $3,555. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a

non-taxable

gain on revaluation/termination of deferred consideration—gold payments and a decrease in the deferred tax asset valuation allowance on losses recognized on the Company’s investments. These items were partly offset by

non-deductible

executive compensation.

The Comp

any’s effective income tax rate during the six months ended June 30, 2023 of 6.5%, resulting in income tax expense of $4,938. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a

non-taxable

gain on revaluation/termination of deferred consideration—gold payments, a $1,353 reduction in unrecognized tax benefits (including interest and penalties) and a lower tax rate on foreign earnings. These items were partly offset by a

non-deductible

loss on extinguishment of our convertible notes,

non-deductible

executive compensation and an increase in the deferred tax asset valuation allowance on losses recognized on our investments.

Effective Income Tax Rate – Three and Six Months Ended June 30, 2022

e Company’s effective income tax rate during the three months ended June 30, 2022 of 25.0% resulted in income tax expense of $2,673. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due a valuation allowance on losses recognized on securities owned and

non-deductible

executive compensation. These items were partly offset by a

non-taxable

gain on revaluation of deferred consideration—gold payments and a lower tax rate on foreign earnings.

The Compan

y’s effective income tax rate benefit during the six months ended June 30, 2022 of 86.2% resulted in an income tax benefit of $14,040. The Company’s effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a $19,897 reduction in unrecognized tax benefits (including interest and penalties) and a lower tax rate on foreign earnings. These items were partly offset by a

non-taxable

loss on revaluation of deferred consideration—gold payments and an increase in the deferred tax asset valuation allowance on losses recognized on financial instruments owned.

Deferred Tax Assets

A summary of the components of the Company’s deferred tax assets at June 30, 2023 and December 31, 2022 is as follows:


	June 30, 2023		December 31, 2022
Deferred tax assets:
Capital losses	$	19,061	$	17,541
Unrealized losses		3,054		3,821
Accrued expenses		2,669		6,030
NOLs—Foreign		1,583		1,609
Stock-based compensation		1,289		1,526
Interest carryforwards		1,209		—
Goodwill and intangible assets		990		1,085
Operating lease liabilities		206		313
Foreign currency translation adjustment		184		173
NOLs—U.S.		127		255
Outside basis differences		122		122
Other		362		341

Deferred tax assets		30,856		32,816

Table of Contents


	June 30, 2023		December 31, 2022
Deferred tax liabilities:
Fixed assets and prepaid assets		577		278
Unremitted earnings—European subsidiaries		210		205
Right of use assets—operating leases		206		313

Deferred tax liabilities		993		796

Total deferred tax assets less deferred tax liabilities		29,863		32,020
Less: Valuation allowance		(22,237)		(21,484)

Deferred tax assets, net		$ 7,626		$ 10,536

Capital Losses – U.S.

The Company’s tax effected capital losses at June 30, 2023 were $

19,061

. These capital losses expire between the years 2023 and 2028.

Net Operating Losses – Europe

One of the Company’s European subsidiaries generated NOLs outside the U.S. These tax effected NOLs, all of which are carried forward indefinitely, were $

1,583

at June 30, 2023.

Valuation Allowance

The Company’s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is

more-likely-than-not

that these deferred tax assets will not be realized.

Income Tax Examinations

The Company is subject to U.S. federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions. As of June 30, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the years before 2018.

Undistributed Earnings of Foreign Subsidiaries

ASC

40-30

Income Taxes provides guidance that U.S. companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $210 and $205 at June 30, 2023 and December 31, 2022, respectively.

21. Shares Repurchased

On Febru

ary 22, 2022, the Company’s Board of Directors approved an increase of $85,709 to the Company’s share repurchase program to $100,000 and extended the term for three years through April 27, 2025. Included under the Company’s share repurchase program are purchases to offset future equity grants made under the Company’s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company’s books and records.

The C

ompany repurchased 26,582 and 631,087 shares of its common stock under this program during the three and six months ended June 30, 2023, and 588,694 during the comparable periods in 2022. The aggregate cost of the shares repurchased during the three and six months ended June 30, 2023 was $156 and $3,540, respectively, and the aggregate cost of the shares repurchased during the comparable periods in 2022 was $3,394. Shares repurchased under this program were returned to the status of authorized and unissued on the Company’s books and records.

As of

June 30, 2023, $96,436 remained under this program for future purchases.

Table of Contents

22. Goodwill and Intangible Assets

Goodwill

The table below sets forth goodwill which is tested annually for impairment on November 30


	Total
Balance at January 1, 2023	$	85,856
Changes		985 (1)

Balance at June 30, 2023	$	86,841

(1)

On April 11, 2023, the Company acquired 100% of the equity interests of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired).

The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill.

the total goodwill of $86,841 at June 30, 2023, $85,042 is not deductible for tax purposes as the acquisitions that gave rise to the goodwill were structured as stock acquisitions. The remainder of the goodwill is deductible for U.S. tax purposes.

Intangible Assets

The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30


	Balance at June 30, 2023
Item	Gross Asset		Accumulated Amortization		Net Asset
ETFS acquisition		$ 601,247		$ —		$ 601,247
Software development		3,316		(156)		3,160

Balance at June 30, 2023		$ 604,563		$ (156)		$ 604,407


	Balance at December 31, 2022
Item	Gross Asset		Accumulated Amortization		Net Asset
ETFS acquisition		$ 601,247		$ —		$ 601,247
Software development		2,370		(50)		2,320

Balance at December 31, 2022		$ 603,617		$ (50)		$ 603,567

ETFS Acquisition (Indefinite-Lived)

In connection with the ETFS Acquisition, which was completed on

April 11, 2018

, the Company identified intangible assets valued at $

601,247

related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.

Software Development (Finite-Lived)

Internally-developed software is amortized over a useful life of

three years

. During the three and six months ended June 30, 2023, the Company recognized amortization expense on internally-developed software of $

106

and $

156

, respectively.

As of June 30, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows:


Remainder of 2023			$ 544
2024			1,087
2025			1,056
2026			454
2027			19
2028 and thereafter			—

Total expected amortization expense			$ 3,160

e weighted-average remaining useful life of the finite-lived intangible assets is 2.9 years.

Table of Contents

23. Contingent Payments

Sale of Canadian ETF Business

n February 19, 2020, the Company completed the sale of all the outstanding shares of WisdomTree Asset Management Canada, Inc. to CI Financial Corp. The Company received CDN $3,720 (USD $2,774) in cash at closing and was paid CDN $3,000 (USD $2,360) and CDN $2,000 (USD $1,477) of additional cash consideration based upon the achievement of certain AUM growth targets as determined on the

18-month

and the

36-month

anniversaries of the closing date, respectively.

A g

ain of $0 and $1,477 was recognized during the three and six months ended June 30, 2023, respectively, from remeasuring the contingent payment to its realizable value. This gain was recorded in other gains and losses, net.

24. Subsequent Events

The Company evaluated subsequent events through the date of issuance of the accompanying consolidated financial statements.

There were no events requiring disclosure.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes and the other financial information included elsewhere in this Report. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below. For a more complete description of the risks noted above and other risks that could cause our actual results to materially differ from our current expectations, please see Item 1A “Risk Factors” in our Annual Report on Form

10-K

for the fiscal year ended December 31, 2022. We assume no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Executive Summary

We are a global financial innovator, offering a well-diversified suite of ETPs, models, solutions and products leveraging blockchain-enabled technology. We empower investors to shape their future and support financial professionals to better serve their clients and grow their businesses. We leverage the latest financial infrastructure to create products that provide access, transparency and an enhanced user experience. Building on our heritage of innovation, we are also developing and recently launched next-generation digital products and structures, including WisdomTree Digital Funds, or “Digital Funds” and tokenized assets, as well as our blockchain-native digital wallet, WisdomTree Prime

™

We have approximately $93.7 billion in AUM as of June 30, 2023. Our family of ETPs includes products that provide exposure to equities, commodities, fixed income,

leveraged-and-inverse,

currency, cryptocurrency and alternative strategies. We have launched many

first-to-market

products and pioneered alternative weighting we call “Modern Alpha,” which combines the outperformance potential of active management with the benefits of passive management to offer investors cost-effective funds that are built to perform. Most of our equity-based funds employ a fundamentally weighted investment methodology, which weights securities based on factors such as dividends, earnings or investment factors, whereas most other industry indexes use a capitalization weighted methodology. These products are distributed through all major channels in the asset management industry, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers primarily through our sales force. We believe technology is altering the way financial advisors conduct business and through our Advisor Solutions program we offer technology-enabled and research-driven solutions including portfolio construction, asset allocation, practice management services and digital tools to help financial advisors address technology challenges and grow and scale their businesses.

We are at the forefront of innovation and believe that tokenization and leveraging the utility of blockchain technology is the next evolution in financial services. We are building the foundation that will allow us to lead in this coming evolution. WisdomTree Prime

™

, our blockchain-native digital wallet, positions us to expand our blockchain-enabled financial services product offerings with a new

direct-to-consumer

channel where spending, saving and investing are united. As we continue to pursue our digital assets strategy, we are embracing a concept we refer to as “responsible DeFi,” which we believe upholds the foundational principles of regulation in this innovative and quickly evolving space. We believe that our expansion into digital assets and blockchain-enabled finance will complement our existing core competencies in a holistic manner, diversify our revenue streams and contribute to our growth.

We were incorporated under the laws of the state of Delaware on September 19, 1985 as Financial Data Systems, Inc., were renamed WisdomTree Investments, Inc. on September 6, 2005, and ultimately renamed WisdomTree, Inc. on November 7, 2022.

Table of Contents

Assets Under Management

WisdomTree ETPs

We offer ETPs covering equity, commodity, fixed income,

leveraged-and-inverse,

currency, alternatives and cryptocurrency. The chart below sets forth the asset mix of our ETPs at June 30, 2023, March 31, 2023 and June 30, 2022:

Market Environment

During the second quarter of 2023, developed markets continued to stave off a recession, as interest rates were relatively stable as compared to the prior quarter. The faster-than-expected

re-opening

of the Chinese economy has also improved the outlook for global growth.

The S&P 500, MSCI EAFE (local currency) and MSCI Emerging Markets Index (U.S. dollar) increased by 8.7%, 4.6% and 1.0%, respectively, during the quarter. In addition, the European and Japanese equities markets both appreciated with the MSCI EMU Index and MSCI Japan Index increasing 3.3% and 15.6%, respectively, in local currency terms for the quarter. Gold prices decreased by 3.4%. The U.S. dollar weakened 0.1% and 2.2% versus the euro and British pound, respectively, and strengthened 8.3% versus the Japanese yen, during the quarter.

Table of Contents

U.S. Listed ETF Industry Flows

U.S. listed ETF industry net flows were $135 billion for the three months ended June 30, 2023. U.S. equity and fixed income gathered the majority of those flows.

Table of Contents

European Listed ETP Industry Flows

European listed ETP industry net flows were $28.9 billion for the three months ended June 30, 2023. Fixed income and equities gathered the majority of those flows.

Our Operating and Financial Results

We operate as an ETP sponsor and asset manager, providing investment advisory services globally through our subsidiaries in the U.S. and Europe.

Table of Contents

U.S. Listed ETFs

The AUM of our U.S. listed exchange traded funds, or U.S. listed ETFs, increased from $61.3 billion at March 31, 2023 to $65.9 billion at June 30, 2023 due to net inflows and market appreciation.

Table of Contents

European Listed ETPs

The AUM of our European listed (including internationally cross-listed) ETPs, or European listed ETPs, decreased from $29.5 billion at March 31, 2023 to $27.8 billion at June 30, 2023, due to net outflows and market depreciation.

Table of Contents

Consolidated Operating Results

The following table sets forth our revenues and net income/(loss) for the most recent five quarters.

•

Revenues

– Total revenues increased 11.0% from the three months ended June 30, 2022 to $85.7 million in the comparable period in 2023 primarily due to higher average AUM.

•

Expenses

– Total operating expenses increased 9.9% from the three months ended June 30, 2022 to $67.5 million in the comparable period in 2023 primarily due to higher professional fees incurred in connection with an activist campaign, incentive compensation and headcount, and fund management and administration costs. These increases were partly offset by lower contractual gold payments.

•

Other Income/(Expenses)

– Other income/(expenses) includes interest income and interest expense, gains on revaluation/termination of deferred consideration–gold payments and other losses and gains. Further information is provided herein.

•

Net income/(loss)

– We reported net income of $54.3 million and $8.0 million during the three months ended June 30, 2023 and 2022, respectively.

Guidance Update for the Year Ending December 31, 2023

Compensation Expense

Our compensation expense for the year ending December 31, 2023 is currently estimated to range from $104.0 million to $110.0 million (previously $100.0 million to $106.0 million). This range considers variability in incentive compensation, with drivers including the magnitude of our flows, our share price performance in relation to our peers as well as revenue, operating income and operating margin performance. Given the potential volatility in our performance-based metrics, we consider the midpoint of this range to be a reasonable estimate.

Discretionary Spending

Discretionary spending includes, marketing, sales, professional fees, occupancy and equipment, depreciation and amortization and other expenses. During the six months ended June 30, 2023, our discretionary spending was $28.3 million. We currently estimate our discretionary spending for the year ending December 31, 2023 to range from $56.0 million to $59.0 million (unchanged from our guidance provided last quarter).

Not included in the guidance above are potential

non-recurring

expenses in response to an activist campaign, including $5.9 million incurred during the six months ended June 30, 2023.

Gross Margin

We define gross margin as total operating revenues less fund management and administration expenses. Gross margin percentage is calculated as gross margin divided by total operating revenues. Our gross margin was 79.2% during the six months ended June 30, 2023. Our gross margin guidance for the year ending December 31, 2023 is estimated to be 79% (previously 78%) which we believe should be sustainable at current AUM levels.

Table of Contents

Contractual Gold Payments

Our contractual gold payments expense of $6.1 million during the six months ended June 30, 2023 will be zero going forward as our obligation to make continuing gold payments was terminated in May 2023.

Third-Party Distribution Fees

We currently estimate third-party distribution fees to range from $8.0 million to $9.0 million (unchanged from our guidance provided last quarter) for the year ending December 31, 2023.

Interest Expense

Our interest expense for the year ending December 31, 2023 is currently estimated to be $15.0 million (unchanged from our guidance provided last quarter).

Interest Income

Our interest income for the year ending December 31, 2023 is currently estimated to be approximately $3.0 million taking into consideration the magnitude of our investments which has been reduced from the prior quarter after having paid approximately $110 million to settle our convertible notes maturing in June and to terminate our deferred consideration—gold payments obligation.

Income Tax Expense

We currently estimate that our consolidated normalized effective tax rate will be 24% (previously 23%) taking into consideration the current distribution of profits amongst our U.S. and European businesses.

This normalized effective tax rate excludes items that are

non-recurring

and not core to our operating business including but not limited to the impact of any revaluation on deferred consideration—gold payments, the loss on extinguishment of convertible notes, remeasurement of contingent consideration from the sale of our former Canadian ETF business, gains and losses on financial instruments owned and investments, valuation allowances on capital losses, reductions in unrecognized tax benefits and any stock-based compensation windfalls or shortfalls.

Diluted Shares Outstanding

Our weighted average diluted shares outstanding were 170.7 million during the three months ended June 30, 2023 after having issued approximately 14 million shares of common stock or instruments convertible into common stock in connection with the termination of our deferred consideration—gold payments obligation and the maturity of our convertible notes during the second quarter. The impact of the share issuance on our second quarter diluted shares was affected by the timing of when the shares were issued. Going forward, we anticipate our diluted shares outstanding to be approximately 177 million per quarter.

Table of Contents

Key Operating Statistics

The following table presents key operating statistics that serve as indicators for the performance of our business:


	Three Months Ended						Six Months Ended
	June 30, 2023		March 31, 2023		June 30, 2022		June 30, 2023		June 30, 2022

GLOBAL ETPs (in millions)
Beginning of period assets	$	90,740	$	81,993	$	79,407	$	81,993	$	77,479
Inflows/(outflows)		2,327		6,341		3,852		8,668		5,171
Market appreciation/(depreciation)		599		2,406		(8,953)		3,005		(8,344)
Fund closures		—		—		(4)		—		(4)

End of period assets	$	93,666	$	90,740	$	74,302	$	93,666	$	74,302

Average assets during the period	$	91,578	$	87,508	$	77,738	$	89,543	$	77,774
Average ETP advisory fee during the period		0.36%		0.36%		0.39%		0.36%		0.39%
Revenue days		91		90		91		181		181
Number of ETPs—end of period		353		350		344		353		344

U.S. LISTED ETFs (in millions)
Beginning of period assets	$	61,283	$	55,973	$	48,622	$	55,973	$	48,210
Inflows/(outflows)		3,249		4,012		4,278		7,261		6,528
Market appreciation/(depreciation)		1,371		1,298		(5,645)		2,669		(7,483)

End of period assets	$	65,903	$	61,283	$	47,255	$	65,903	$	47,255

Average assets during the period	$	62,712	$	59,430	$	48,270	$	61,071	$	47,885
Number of ETFs – end of the period		80		80		77		80		77

EUROPEAN LISTED ETPs (in millions)
Beginning of period assets	$	29,457	$	26,020	$	30,785	$	26,020	$	29,269
(Outflows)/inflows		(922)		2,329		(426)		1,407		(1,357)
Market (depreciation)/appreciation		(772)		1,108		(3,308)		336		(861)
Fund closures		—		—		(4)		—		(4)

End of period assets	$	27,763	$	29,457	$	27,047	$	27,763	$	27,047

Average assets during the period	$	28,866	$	28,078	$	29,468	$	28,472	$	29,889
Number of ETPs—end of period		273		270		267		273		267

PRODUCT CATEGORIES (in millions)

U.S. Equity
Beginning of period assets	$	24,534	$	24,112	$	23,738	$	24,112	$	23,860
Inflows/(outflows)		414		(149)		306		265		1,085
Market appreciation/(depreciation)		1,053		571		(2,986)		1,624		(3,887)

End of period assets	$	26,001	$	24,534	$	21,058	$	26,001	$	21,058

Average assets during the period	$	24,732	$	24,726	$	22,362	$	24,729	$	22,748

Commodity & Currency
Beginning of period assets	$	24,924	$	22,097	$	26,302	$	22,097	$	24,598
(Outflows)/inflows		(1,512)		2,003		(475)		491		(1,528)
Market (depreciation)/appreciation		(1,028)		824		(2,203)		(204)		554

End of period assets	$	22,384	$	24,924	$	23,624	$	22,384	$	23,624

Average assets during the period	$	24,033	$	23,806	$	25,767	$	23,918	$	25,827

Fixed Income
Beginning of period assets	$	18,708	$	15,273	$	5,418	$	15,273	$	4,356
Inflows/(outflows)		1,471		3,513		4,038		4,984		5,280
Market appreciation/(depreciation)		36		(78)		(264)		(42)		(444)

End of period assets	$	20,215	$	18,708	$	9,192	$	20,215	$	9,192

Average assets during the period	$	19,185	$	17,176	$	7,426	$	18,181	$	6,059

International Developed Market Equity
Beginning of period assets	$	11,433	$	10,195	$	11,422	$	10,195	$	11,894
Inflows/(outflows)		1,592		450		79		2,042		176
Market appreciation/(depreciation)		398		788		(1,533)		1,186		(2,102)

End of period assets	$	13,423	$	11,433	$	9,968	$	13,423	$	9,968

Average assets during the period	$	12,276	$	10,879	$	10,695	$	11,578	$	11,119

Table of Contents


	Three Months Ended						Six Months Ended
	June 30, 2023		March 31, 2023		June 30, 2022		June 30, 2023		June 30, 2022

Emerging Market Equity
Beginning of period assets	$	8,811	$	8,116	$	9,991	$	8,116	$	10,375
Inflows/(outflows)		329		486		(223)		815		(34)
Market appreciation/(depreciation)		51		209		(1,382)		260		(1,955)

End of period assets	$	9,191	$	8,811	$	8,386	$	9,191	$	8,386

Average assets during the period	$	8,998	$	8,666	$	9,155	$	8,832	$	9,636

Leveraged & Inverse
Beginning of period assets	$	1,785	$	1,754	$	1,856	$	1,754	$	1,775
Inflows/(outflows)		12		43		90		55		88
Market appreciation/(depreciation)		67		(12)		(328)		55		(245)

End of period assets	$	1,864	$	1,785	$	1,618	$	1,864	$	1,618

Average assets during the period	$	1,798	$	1,757	$	1,765	$	1,778	$	1,798

Alternatives
Beginning of period assets	$	306	$	310	$	293	$	310	$	261
Inflows/(outflows)		22		(18)		34		4		63
Market appreciation/(depreciation)		12		14		(22)		26		(19)

End of period assets	$	340	$	306	$	305	$	340	$	305

Average assets during the period	$	320	$	308	$	299	$	314	$	287

Cryptocurrency
Beginning of period assets	$	239	$	136	$	383	$	136	$	357
(Outflows)/inflows		(1)		13		3		12		40
Market appreciation/(depreciation)		10		90		(235)		100		(246)

End of period assets	$	248	$	239	$	151	$	248	$	151

Average assets during the period	$	236	$	190	$	265	$	213	$	295

Closed ETPs
Beginning of period assets	$	—	$	—	$	4	$	—	$	3
Inflows/(outflows)		—		—		—		—		1
Fund closures		—		—		(4)		—		(4)

End of period assets	$	—	$	—	$	—	$	—	$	—

Average assets during the period	$	—	$	—	$	4	$	—	$	5

Headcount:		291		279		264		291		264

Note: Previously issued statistics may be restated due to fund closures and trade adjustments

Source: WisdomTree

Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022

Selected Operating and Financial Information


	Three Months Ended June 30,				Change		Percent Change
	2023		2022		Change		Percent Change

AUM (in millions)
Average AUM	$	91,578	$	77,738	$	13,840		17.8%


Operating Revenues (in thousands)
Advisory fees	$	82,004	$	75,586	$	6,418		8.5%
Other income		3,720		1,667		2,053		123.2%

Total revenues	$	85,724	$	77,253	$	8,471		11.0%

Operating Revenues

Advisory fees

Advisory fee revenues increased 8.5% from $75.6 million during the three months ended June 30, 2022 to $82.0 million in the comparable period in 2023 due to higher average AUM, partially offset by lower average advisory fee. Our average advisory fee was 0.36% during the three months ended June 30, 2023 and 0.39% during the comparable period in 2022.

Table of Contents

Other income

Other income increased 123.2% from $1.7 million during the three months ended June 30, 2022 to $3.7 million in the comparable period in 2023 primarily due to large flows into some of our European products.

Operating Expenses


(in thousands)	Three Months Ended June 30,				Change		Percent Change
(in thousands)	2023		2022		Change		Percent Change
Compensation and benefits	$	26,319	$	24,565	$	1,754		7.1%
Fund management and administration		17,727		16,076		1,651		10.3%
Marketing and advertising		4,465		3,894		571		14.7%
Sales and business development		3,326		3,131		195		6.2%
Contractual gold payments		1,583		4,446		(2,863)		(64.4%)
Professional fees		8,334		4,308		4,026		93.5%
Occupancy, communications and equipment		1,172		1,049		123		11.7%
Depreciation and amortization		121		53		68		128.3%
Third-party distribution fees		1,881		1,818		63		3.5%
Other		2,615		2,109		506		24.0%

Total operating expenses	$	67,543	$	61,449	$	6,094		9.9%


As a Percent of Revenues:	Three Months Ended June 30,
As a Percent of Revenues:	2023		2022
Compensation and benefits		30.7%		31.6%
Fund management and administration		20.7%		20.8%
Marketing and advertising		5.2%		5.0%
Sales and business development		3.9%		4.1%
Contractual gold payments		1.8%		5.8%
Professional fees		9.7%		5.6%
Occupancy, communications and equipment		1.4%		1.4%
Depreciation and amortization		0.1%		0.1%
Third-party distribution fees		2.2%		2.4%
Other		3.1%		2.7%

Total operating expenses		78.8%		79.5%

Compensation and benefits

Compensation and benefits expense increased 7.1% from $24.6 million during the three months ended June 30, 2022 to $26.3 million in the comparable period in 2023 due to increased headcount and higher stock-based compensation expense, partly offset by lower incentive compensation. Headcount was 264 and 291 at June 30, 2022 and 2023, respectively.

Fund management and administration

Fund management and administration expense increased 10.3% from $16.1 million during the three months ended June 30, 2022 to $17.7 million in the comparable period in 2023 primarily due to higher average AUM, product launches and inflows. We had 77 U.S. listed ETFs and 267 European listed ETPs at June 30, 2022 compared to 80 U.S. listed ETFs and 273 European listed ETPs at June 30, 2023.

Marketing and advertising

Marketing and advertising expense increased 14.7% from $3.9 million during the three months ended June 30, 2022 to $4.5 million in the comparable period in 2023 primarily due to higher spending related to our U.S. listed products.

Sales and business development

Sales and business development expense was essentially unchanged from the three months ended June 30, 2022.

Table of Contents

Contractual gold payments

Contractual gold payments expense decreased 64.4% from $4.4 million during the three months ended June 30, 2022 to $1.6 million in the comparable period in 2023 due to the termination of our deferred consideration—gold payments obligation on May 10, 2023. See Note 9 to our Consolidated Financial Statements for additional information.

Professional fees

Professional fees increased 93.5% from $4.3 million during the three months ended June 30, 2022 to $8.3 million in the comparable period in 2023 primarily due to higher expenses incurred in response to an activist campaign as well as expenses incurred to settle our deferred consideration—gold payments obligation and our acquisition of WisdomTree Transfers, Inc.

Occupancy, communications and equipment

Occupancy, communications and equipment expense was essentially unchanged from the three months ended June 30, 2022.

Depreciation and amortization

Depreciation and amortization expense increased 128.3% due to amortization of software development costs.

Third-party distribution fees

Third-party distribution fees were essentially unchanged from the three months ended June 30, 2022.

Other

Other expenses increased 24.0% from $2.1 million during the three months ended June 30, 2022 to $2.6 million in the comparable period in 2023 primarily due to higher travel, public relations and directors expenses.

Other Income/(Expenses)


(in thousands)	Three Months Ended June 30,						Change			Percent Change
(in thousands)	2023			2022			Change			Percent Change
Interest expense	$	(4,021	)	$	(3,733	)	$	(288	)		7.7	%
Gain on revaluation/termination of deferred consideration—gold payments		41,361			2,311			39,050			1,689.7	%
Interest income		1,000			770			230			29.9	%
Other gains and losses, net		1,286			(4,474	)		5,760			n/a

Total other income/(expenses), net	$	39,626		$	(5,126	)	$	44,752			n/a


	Three Months Ended June 30,
As a Percent of Revenues:	2023			2022
Interest expense		(4.7	%)		(4.8	%)
Gain on revaluation/termination of deferred consideration—gold payments		48.2	%		3.0	%
Interest income		1.2	%		1.0	%
Other gains and losses, net		1.5	%		(5.8	%)

Total other income/(expenses), net		46.2	%		(6.6	%)

Interest expense

Interest expense increased 7.7% from $3.7 million during the three months ended June 30, 2022 to $4.0 million in the comparable period in 2023 due to a higher level of debt outstanding and a higher effective interest rate. Our effective interest rate during the three months ended June 30, 2022 and 2023 was 4.6% and 5.0%, respectively.

Gain on revaluation/termination of deferred consideration—gold payments

We recognized a gain on revaluation/termination of deferred consideration—gold payments of $41.4 million and $2.3 million during the three months ended June 30, 2023 and 2022, respectively. This obligation was settled on May 10, 2023 for approximately $137.0 million. See Note 9 to our Consolidated Financial Statements for additional information.

Table of Contents

Interest income

Interest income increased 29.9% from $0.8 million during the three months ended June 30, 2022 to $1.0 million in the comparable period in 2023 due to, partially offset by a decrease in our financial instruments owned.

Other gains and losses, net

Other gains and losses, net was $1.3 million for the second quarter of 2023. This quarter includes gains on our investments of $3.1 million, partly offset by losses on our financial instruments owned of $1.0 million. Gains and losses also generally arise from the sale of gold earned from management fees paid by our physically-backed gold ETPs, foreign exchange fluctuations and other miscellaneous items.

Income Taxes

Our effective income tax rate for the second quarter of 2023 was 6.1%, resulting in income tax expense of $3.6 million. The effective tax rate differs from the federal statutory rate of 21% primarily due to a

non-taxable

gain on revaluation/termination of deferred consideration—gold payments and a decrease in the deferred tax asset valuation allowance on losses recognized on our investments. These items were partly offset by

non-deductible

executive compensation.

Our effective income tax rate for the second quarter of 2022 of 25.0% resulted in an income tax expense of $2.7 million. Our tax rate differs from the federal statutory rate of 21% primarily due to a valuation allowance on losses recognized on securities owned and

non-deductible

compensation. These items were partly offset by a

non-taxable

gain on revaluation of deferred consideration—gold payments and a lower tax rate on foreign earnings.

Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022

Selected Operating and Financial Information


	Six Months Ended June 30,				Change		Percent Change
	2023		2022		Change		Percent Change
AUM (in millions)
Average AUM	$	89,543	$	77,774	$	11,769		15.1%

Operating Revenues (in thousands)
Advisory fees	$	159,641	$	152,103	$	7,538		5.0%
Other income		8,127		3,518		4,609		131.0%

Total revenues	$	167,768	$	155,621	$	12,147		7.8%

Operating Revenues

Advisory fees

Advisory fee revenues increased 5.0% from $152.1 million during the six months ended June 30, 2022 to $159.6 million in the comparable period in 2023 due to higher average AUM, partially offset by lower average advisory fee. Our average advisory fee was 0.39% during the six months ended June 30, 2022 and 0.36% during the comparable period in 2023.

Other income

Other income increased 131.0% from $3.5 million during the six months ended June 30, 2022 to $8.1 million in the comparable period in 2023 primarily due to large flows into some of our European products.

Table of Contents

Operating Expenses


(in thousands)	Six Months Ended June 30,				Change		Percent Change
(in thousands)	2023		2022		Change		Percent Change
Compensation and benefits	$	53,717	$	49,352	$	4,365		8.8%
Fund management and administration		34,880		31,570		3,310		10.5%
Marketing and advertising		8,472		7,917		555		7.0%
Sales and business development		6,320		5,740		580		10.1%
Contractual gold payments		6,069		8,896		(2,827)		(31.8%)
Professional fees		12,049		8,767		3,282		37.4%
Occupancy, communications and equipment		2,273		1,802		471		26.1%
Depreciation and amortization		230		100		130		130.0%
Third-party distribution fees		4,134		4,030		104		2.6%
Other		4,872		3,954		918		23.2%

Total operating expenses	$	133,016	$	122,128	$	10,888		8.9%


As a Percent of Revenues:	Six Months Ended June 30,
As a Percent of Revenues:	2023		2022
Compensation and benefits		32.0%		31.7%
Fund management and administration		20.8%		20.3%
Marketing and advertising		5.0%		5.1%
Sales and business development		3.8%		3.7%
Contractual gold payments		3.6%		5.7%
Professional fees		7.2%		5.6%
Occupancy, communications and equipment		1.4%		1.2%
Depreciation and amortization		0.1%		0.1%
Third-party distribution fees		2.5%		2.6%
Other		2.9%		2.5%

Total operating expenses		79.3%		78.5%

Compensation and benefits

Compensation and benefits expense increased 8.8% from $49.4 million during the six months ended June 30, 2022 to $53.7 million in the comparable period in 2023 due to increased headcount, stock-based compensation expense, payroll taxes and benefits, partly offset by lower incentive compensation.

Fund management and administration

Fund management and administration expense increased 10.5% from $31.6 million during the six months ended June 30, 2022 to $34.9 million in the comparable period in 2023 primarily due to higher average AUM, product launches and inflows.

Marketing and advertising

Marketing and advertising expense increased 7.0% from $7.9 million during the three months ended June 30, 2022 to $8.5 million in the comparable period in 2023 primarily due to higher spending related to our U.S. listed products.

Sales and business development

Sales and business development expense increased 10.1% from $5.7 million during the six months ended June 30, 2022 to $6.3 million in the comparable period in 2023 primarily resulting from increases in travel, conference and events spending.

Contractual gold payments

Contractual gold payments expense decreased 31.8% from $8.9 million during the six months ended June 30, 2022 to $6.1 million in the comparable period in 2023 due to the termination of our deferred consideration—gold payments obligation on May 10, 2023. See Note 9 to our Consolidated Financial statements for additional information.

Table of Contents

Professional fees

Professional fees increased 37.4% from $8.8 million during the six months ended June 30, 2022 to $12.0 million in the comparable period in 2023 primarily due to higher expenses incurred in response to an activist campaign, as well as expenses incurred to settle our deferred consideration—gold payments obligation and our acquisition of WisdomTree Transfers, Inc.

Occupancy, communications and equipment

Occupancy, communications and equipment expense increased 26.1% from $1.8 million during the six months ended June 30, 2022 to $2.3 million in the comparable period in 2023 as our New York office lease became effective in May 2022.

Depreciation and amortization

Depreciation and amortization expense increased 130.0% from $0.1 million during the six months ended June 30, 2022 to $0.2 million in the comparable period in 2023 due to amortization of software development costs.

Third-party distribution fees

Third-party distribution fees were essentially unchanged from the six months ended June 30, 2022.

Other

Other expenses increased 23.2% from $4.0 million during the six months ended June 30, 2022 to $4.9 million in the comparable period in 2023 primarily due to higher travel, public relations and directors expenses.

Other Income/(Expenses)


(in thousands)	Six Months Ended June 30,				Change		Percent Change
(in thousands)	2023		2022		Change		Percent Change
Interest expense	$	(8,023)	$	(7,465)	$	(558)		7.5%
Gain/(loss) on revaluation/termination of deferred consideration—gold payments		61,953		(14,707)		76,660		n/a
Interest income		2,083		1,564		519		33.2%
Impairments		(4,900)		—		(4,900)		n/a
Loss on extinguishment of convertible notes		(9,721)		—		(9,721)		n/a
Other losses, net		(721)		(29,181)		28,460		(97.5%)

Total other income/(expenses), net	$	40,671	$	(49,789)	$	90,460		n/a


	Six Months Ended June 30,
As a Percent of Revenues:	2023		2022
Interest expense		(4.8%)		(4.8%)
Gain/(loss) on revaluation/termination of deferred consideration—gold payments		36.9%		(9.5%)
Interest income		1.2%		1.0%
Impairments		(2.9%)		—
Loss on extinguishment of convertible notes		(5.8%)		—
Other losses, net		(0.4%)		(18.7%)

Total other income/(expenses), net		24.2%		(32.0%)

Interest expense

Interest expense increased 7.5% from $7.5 million during the six months ended June 30, 2022 to $8.0 million in the comparable period in 2023 due to a higher level of debt outstanding and a higher effective interest rate. Our effective interest rate during the six months ended June 30, 2022 and 2023 was 4.6% and 4.9%, respectively.

Gain/(loss) on revaluation/termination of deferred consideration—gold payments

We recognized a loss on revaluation of deferred consideration—gold payments of ($14.7) million and a gain on revaluation/termination of deferred consideration—gold payments of $62.0 million during the six months ended June 30, 2022 and 2023, respectively. This obligation was settled on May 10, 2023 for approximately $137.0 million. See Note 9 to our Consolidated Financial Statements for additional information.

Table of Contents

Interest income

Interest income increased 33.2% from $1.6 million during the six months ended June 30, 2022 to $2.1 million in the comparable period in 2023 due to rising interest rates, partially offset by a decrease in our financial instruments owned.

Impairments

During the six months ended June 30, 2023, we recognized a

non-cash

impairment charge of $4.9 million on the Securrency Series A Shares.

Loss on Extinguishment of Convertible Notes

During the six months ended June 30, 2023, we recognized a loss on extinguishment of convertible notes of $9.7 million arising from the repurchase of $115.0 million in aggregate principal amount of our 2020 Notes.

Other losses, net

Other net losses were $0.7 million during the six months ended June 30, 2023. This period includes a

non-cash

charge of $1.4 million arising from the release of

tax-related

indemnification assets upon the expiration of the statute of limitations (an equal and offsetting benefit was recognized in income tax expense); gains on our financial instruments owned of $0.9 million and losses on our investments of $0.8 million. Gains and losses also generally arise from the sale of gold earned on management fees paid by our physically-backed gold ETPs, foreign exchange fluctuations and other miscellaneous items.

Income Taxes

Our effective income tax rate for the six months ended June 30, 2023 was 6.5%, resulting in an income tax expense of $4.9 million. Our tax rate differs from the federal statutory rate of 21% primarily due to a

non-taxable

gain on revaluation/termination of deferred consideration—gold payments, a reduction in unrecognized tax benefits associated with the release of the

tax-related

indemnification asset described above and a lower tax rate on foreign earnings. These items were partly offset by a

non-deductible

loss on extinguishment of our convertible notes during the first quarter of 2023,

non-deductible

executive compensation and an increase in the deferred tax asset valuation allowance on losses recognized on our investments.

Our effective income tax rate benefit for the six months ended June 30, 2022 was 86.2% resulting in an income tax benefit of $14.0 million. Our tax rate differs from the federal statutory rate of 21% primarily due to a reduction in unrecognized tax benefits associated with the release of the

tax-related

indemnification asset described above and a lower tax rate on foreign earnings. These items were partly offset by a

non-taxable

loss on revaluation of deferred consideration—gold payments and an increase in the deferred tax asset valuation allowance on losses recognized on our financial instruments owned.

Non-GAAP

Financial Measurements

In an effort to provide additional information regarding our results as determined by GAAP, we also disclose certain

non-GAAP

information which we believe provides useful and meaningful information. Our management reviews these

non-GAAP

financial measurements when evaluating our financial performance and results of operations; therefore, we believe it is useful to provide information with respect to these

non-GAAP

measurements so as to share this perspective of management.

Non-GAAP

measurements do not have any standardized meaning, do not replace nor are superior to GAAP financial measurements and are unlikely to be comparable to similar measures presented by other companies. These

non-GAAP

financial measurements should be considered in the context with our GAAP results. The

non-GAAP

financial measurements contained in this Report include:

•

Adjusted net income and diluted earnings per share.

We disclose adjusted net income and diluted earnings per share as

non-GAAP

financial measurements in order to report our results exclusive of items that are

non-recurring

or not core to our operating business. We believe presenting these

non-GAAP

financial measurements provides investors with a consistent way to analyze our performance. These

non-GAAP

financial measurements exclude the following:

•

Unrealized gains or losses on revaluation/termination of deferred consideration—gold payments:

Deferred consideration—gold payments was an obligation we assumed in connection with the ETFS Acquisition that was carried at fair value. This item represented the present value of an obligation to pay fixed ounces of gold into perpetuity and is measured using forward-looking gold prices. Changes in the forward-looking price of gold and changes in the discount rate used to compute the present value of the annual payment obligations have had a material impact on the carrying value of the deferred consideration and our reported financial results. We exclude this item when arriving at adjusted net income and diluted earnings per share as it was not core to our operating business. The item is not adjusted for income taxes as the obligation was assumed by a wholly-owned subsidiary of ours that is based in Jersey, a jurisdiction where we are subject to a zero percent tax rate. During the second quarter of 2023, we terminated this obligation for aggregate consideration totaling approximately $137.0 million.

Table of Contents

•

Gains or losses on financial instruments owned:

We account for our financial instruments owned as trading securities, which requires these instruments to be measured at fair value with gains and losses reported in net income. We exclude these items when calculating our

non-GAAP

financial measurements as the gains and losses introduce volatility in earnings and are not core to our operating business.

•

Tax windfalls and shortfalls upon vesting and exercise of stock-based compensation awards:

GAAP requires the recognition of tax windfalls and shortfalls within income tax expense. These items arise upon the vesting and exercise of stock-based compensation awards and the magnitude is directly correlated to the number of awards vesting/exercised as well as the difference between the price of our stock on the date the award was granted and the date the award vested or was exercised. We exclude these items when determining adjusted net income and diluted earnings per share as they introduce volatility in earnings and are not core to our operating business.

•

Other items:

Loss on extinguishment of our convertible notes, impairments, remeasurement of contingent consideration payable to us from the sale of our former Canadian ETF business, unrealized gains and losses recognized on our investments, changes in deferred tax asset valuation allowance, expenses incurred in response to an activist campaign and litigation expenses associated with certain provisions of our Stockholder Rights Agreement are excluded when calculating our

non-GAAP

financial measurements.


	Three Months Ended						Six Months Ended
	June 30,			June 30,			June 30,			June 30,
Adjusted Net Income and Diluted Earnings per Share:	2023			2022			2023			2022
Net income/(loss), as reported	$	54,252		$	8,005		$	70,485		$	(2,256	)
Deduct/add back: (Gain)/loss on revaluation/termination of deferred consideration—gold payments		(41,361	)		(2,311	)		(61,953	)		14,707
Add back: Expenses incurred in response to an activist campaign, net of income taxes		3,720			1,532			4,452			3,376
Deduct/add back: Unrealized (gain)/loss recognized on our investments, net of income taxes		(2,346	)		(55	)		620			69
Add back/(deduct): Losses/(gains) on financial instruments owned, net of income taxes		762			3,165			(717	)		7,058
(Deduct)/add back: (Decrease)/increase in deferred tax asset valuation allowance on financial instruments owned and investments		(508	)		901			(31	)		2,911
Add back: Litigation expenses associated with certain provisions of the Stockholder Rights Agreement, net of income taxes		367			—			367			—
Add back/(deduct): Tax shortfalls/(windfalls) upon vesting and exercise of stock-based compensation awards		33			20			(152	)		(545	)
Add back: Loss on extinguishment of convertible notes, net of income taxes		—			—			9,623			—
Add back: Impairments, net of income taxes (where applicable)		—			—			4,900			—
Deduct: Remeasurement of contingent consideration—sale of former Canadian ETF business		—			—			(1,477	)		—

Adjusted net income	$	14,919		$	11,257		$	26,117		$	25,320
Deduct: Income distributed to participating securities		(496	)		(548	)		(994	)		(1,097	)
Deduct: Undistributed income allocable to participating securities		(1,410	)		(724	)		(2,028	)		(1,763	)

Adjusted net income available to common stockholders	$	13,013		$	9,985		$	23,095		$	22,460
Weighted average diluted shares, excluding participating securities (in thousands) (See Note 11 to our Consolidated Financial Statements)		147,815			143,425			146,155			143,271

Adjusted earnings per share – diluted	$	0.09		$	0.07		$	0.16		$	0.16

Table of Contents

Liquidity and Capital Resources

The following table summarizes key data regarding our liquidity, capital resources and use of capital to fund our operations:


	June 30, 2023			December 31, 2022
Balance Sheet Data (in thousands):
Cash and cash equivalents	$	83,735		$	132,101
Financial instruments owned, at fair value		65,492			126,239
Accounts receivable		34,208			30,549
Securities held-to-maturity		245			259

Total: Liquid assets		183,680			289,148
Less: Total current liabilities		(68,281	)		(148,434	)
Less: Other assets—seed capital (WisdomTree Digital Funds)		(12,876	)		(1,765	)
Less: Regulatory capital requirements		(24,912	)		(25,988	)

Total: Available liquidity	$	77,611		$	112,961


	Six Months Ended June 30,
	2023		2022
Cash Flow Data (in thousands):
Operating cash flows	$	20,029	$	8,542
Investing cash flows		51,936		(23,070)
Financing cash flows		(121,109)		(13,073)
Foreign exchange rate effect		778		(3,372)

Decrease in cash and cash equivalents	$	(48,366)	$	(30,973)

Liquidity

We consider our available liquidity to be our liquid assets, less our current liabilities, seed capital in WisdomTree Digital Funds and regulatory capital requirements. Liquid assets consist of cash and cash equivalents, financial instruments owned, at fair value, accounts receivable and securities

held-to-maturity.

Our financial instruments owned, at fair value are highly liquid investments. Accounts receivable are current assets and primarily represent receivables from advisory fees we earn from our ETPs. Our current liabilities consist primarily of payments owed to vendors and third parties in the normal course of business and accrued incentive compensation for employees.

Cash and cash equivalents decreased by $48.3 million during the six months ended June 30, 2023 due to $184.3 million used to repurchase and settle at maturity our convertible notes, $50.0 million used to settle our deferred consideration—gold payments obligation, $40.5 million used to purchase financial instruments owned, at fair value, $10.0 million used to purchase investments, $9.7 million used to pay dividends, $3.5 million used to repurchase our common stock, $3.5 million used for convertible notes issuance costs and $1.0 million used to acquire Securrency Transfers, Inc (renamed WisdomTree Transfers, Inc.). These decreases were partly offset by $130.0 million of proceeds from the issuance of convertible notes, $102.0 million of proceeds from the sale of financial instruments owned, at fair value, $20.0 million provided by operating activities, $1.5 million from receipt of contingent consideration and $0.7 million from other activities.

Cash and cash equivalents decreased $31.0 million during the six months ended June 30, 2022 due to $32.5 million used to purchase securities owned, $11.9 million used to purchase investments, $9.7 million used to pay dividends on our common stock, $3.4 million used to repurchase our common stock, $3.4 million of foreign exchange rate losses and $0.1 million used in other activities. These decreases were partly offset by $21.5 million of proceeds from the sale of securities owned and $8.5 million of net cash provided by operating activities.

Issuance of Convertible Notes

On February 14, 2023, we issued and sold $130.0 million in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between us and U.S. Bank Trust Company, National Association, as trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”).

On June 14, 2021, we issued and sold $150.0 million in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A.

Table of Contents

On June 16, 2020, we issued and sold $150.0 million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, we issued and sold $25.0 million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, which constitute a further issuance of, and form a single series with, our June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”).

In connection with the issuance of the 2023 Notes, we repurchased $115.0 million in aggregate principal amount of the 2020 Notes. As a result of this repurchase, we recognized a loss on extinguishment of approximately $9.7 million during the six months ended June 30, 2023. The remainder of the 2020 Notes matured on June 15, 2023 and were settled for approximately $59.9 million of cash and approximately 1.0 million shares of common stock of the Company.

After the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (and together with the 2021 Notes, the “Convertible Notes”), we had $280.0 million in aggregate principal amount of Convertible Notes outstanding.

Key terms of the Convertible Notes are as follows:


	2023 Notes		2021 Notes
Principal outstanding		$130.0		$150.0
Maturity date (unless earlier converted, repurchased or redeemed)		August 15, 2028		June 15, 2026
Interest rate		5.75%		3.25%
Conversion price		$9.54		$11.04
Conversion rate		104.8658		90.5797
Redemption price		$12.40		$14.35

•

Interest rate:

Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and on June 15 and December 15 of each year for the 2021 Notes.

•

Conversion price:

Convertible at an initial conversion rate into shares of our common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.

•

Conversion:

Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028 and March 15, 2026 for the 2023 Notes and the 2021 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of our common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of our common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by us in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028 and March 15, 2026 in respect of the 2023 Notes, and the 2021 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert

their

Convertible Notes at any time, regardless of the foregoing circumstances.

•

Cash settlement of principal amount:

Upon conversion, we will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At our election, we will also settle our conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of our common stock or a combination of cash and shares of its common stock.

•

Redemption price:

We may redeem for cash all or any portion of the Convertible Notes, at our option, on or after August 20, 2025 and June 20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55

scheduled trading day immediately preceding the maturity date, if the last reported sale price of our common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.

•

Limited investor put rights:

Holders of the Convertible Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.

Table of Contents

•

Conversion rate increase in certain customary circumstances:

In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares and 144.9275 shares of our common stock per $1,000 principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of 43,551,214 shares of our common stock), subject to adjustment.

•

Seniority and Security:

The Convertible Notes rank equal in right of payment, and are our senior unsecured obligations, but are subordinated in right of payment to our obligations to make certain redemption payments (if and when due) in respect of its Series A

Non-Voting

Convertible Preferred Stock (See Note 11 to our Consolidated Financial Statements).

The indentures contain customary terms and covenants, including that upon certain events

default occurring and continuing, either the trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.

Capital Resources

Our principal source of financing is our operating cash flow. We believe that current cash flows generated by our operating activities and existing cash balances should be sufficient for us to fund our operations for the foreseeable future.

Our ability to satisfy our contractual obligations as they arise are discussed in the section titled “Contractual Obligations” below.

Use of Capital

Our business does not require us to maintain a significant cash position. However, certain of our subsidiaries are required to maintain a minimum level of regulatory capital, which at June 30, 2023 was approximately $24.9 million in the aggregate. Notwithstanding these regulatory capital requirements, we expect that our main uses of cash will be to fund the ongoing operations of our business. We also maintain a capital return program which includes a $0.03 per share quarterly cash dividend and authority to purchase our common stock through April 27, 2025, including purchases to offset future equity grants made under our equity plans and purchases made in open market or privately negotiated transactions.

During the six months ended June 30, 2023, we repurchased 631,087 shares of our common stock under the repurchase program for an aggregate cost of $3.5 million. Currently, approximately $96.4 million remains under this program for future purchases.

In addition, during the three months ended June 30, 2023, we paid approximately $50.0 million in cash to settle our deferred consideration—gold payments obligation (see Note 10 to our Consolidated Financial Statements for additional information) and also paid approximately $59.9 million in cash upon the maturity of our 2020 Notes.

Contractual Obligations

Convertible Notes

We currently have $280.0 million in aggregate principal amount of Convertible Notes outstanding, of which $150.0 million and $130.0 million are scheduled to mature on June 15, 2026 and August 15, 2028 in respect of the 2021 Notes and the 2023 Notes, respectively, unless earlier converted, repurchased or redeemed. Conditional conversions or a requirement to repurchase the Convertible Notes upon the occurrence of a fundamental change may accelerate payment.

The Convertible Notes require cash settlement of up to the principal amount, while settlement of the conversion obligation in excess of the aggregate principal amount may be satisfied in either cash, shares of our common stock or a combination of cash and shares of our common stock. We may settle and/or refinance these obligations when due.

See the section titled “Issuance of Convertible Notes” above for additional information.

Deferred Consideration—Gold Payments

On May 10, 2023, the Company entered into and closed on a Sale, Purchase and Assignment Deed to terminate the Company’s obligations relating to the contractual gold payments. Pursuant to that agreement, the Company paid consideration totaling $136.9 million, including an aggregate of $50.0 million in cash and the issuance of 13,087 shares of Series C Non-Voting Convertible Preferred Stock (valued at $86.9 million), which are convertible into 13,087,000 shares of the Company’s common stock.

See Note 9 to our Consolidated Financial Statements for additional information.

Operating Leases

Total future minimum lease payments with respect to our operating lease liabilities were $0.9 million at June 30, 2023. Cash flows generated by our operating activities and existing cash balances should be sufficient to satisfy the future minimum lease payments.

Table of Contents

See Note 12 to our Consolidated Financial Statements for additional information.

Off-Balance

Sheet Arrangements

We do not have any

off-balance

sheet financing or other arrangements and have neither created nor are party to any special-purpose or

off-balance

sheet entities for the purpose of raising capital, incurring debt or operating our business.

Critical Accounting Policies and Estimates

Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. We test goodwill for impairment at least annually and at the time of a triggering event requiring

re-evaluation,

Goodwill is allocated to our U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.

Goodwill is assessed for impairment annually on November 30

. When performing our goodwill impairment test, we consider a qualitative assessment, when appropriate, and the market approach and its market capitalization when determining the fair value of the reporting unit. The results of our most recent analysis indicated no impairment based upon a quantitative assessment.

Indefinite-lived intangible assets are tested for impairment at least annually and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair value is less than their carrying value. We may rely on a qualitative assessment when performing our intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for our intangible assets is November 30

. The results of our most recent analysis indicated no impairment based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including projected revenue growth rates ranging from 3% to 8% (5% weighted average) and a weighted average cost of capital of 11.0%.

Investments

We account for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed within ASU

2016-01,

Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities

, to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.

Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).

See Note 7 to our Consolidated Financial Statements for information.

Revenue Recognition

We earn substantially all of our revenue in the form of advisory fees from our ETPs and recognize this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which we have a right to invoice.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The following information, together with information included in other parts of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, describes key aspects of our market risk.

Table of Contents

Market Risk

Market risk to us generally represents the risk of changes in the value of our ETPs and Digital Funds that results from fluctuations in securities or commodity prices, foreign currency exchange rates against the U.S. dollar, and interest rates. Nearly all our revenues are derived from advisory agreements for the WisdomTree ETPs. Under these agreements, the advisory fee we receive is based on the average market value of the assets in the WisdomTree ETP portfolios we manage.

Fluctuations in the value of the ETPs are common and are generated by numerous factors such as market volatility, the global economy, inflation, changes in investor strategies and sentiment, availability of alternative investment vehicles, domestic and foreign government regulations, emerging markets developments and others. Accordingly, changes in any one or a combination of these factors may reduce the value of investment securities and, in turn, the underlying AUM on which our revenues are earned. These declines may cause investors to withdraw funds from our ETPs in favor of investments that they perceive as offering greater opportunity or lower risk, thereby compounding the impact on our revenues. We believe challenging and volatile market conditions will continue to be present in the foreseeable future.

Interest Rate Risk

We invest our corporate cash in short-term interest earning assets, primarily in federal agency debt instruments, WisdomTree fixed income ETFs, U.S. treasuries, corporate bonds, money market instruments at a commercial bank and other securities which totaled $131.1 million and $65.9 million as of June 30, 2022 and 2023, respectively. During the six months ended June 30, 2023, we recognized gains on these financial instruments of $0.9 million and any gains/losses recognized in the future may be material to our operating results. We do not anticipate that changes in interest rates will have a material impact on our financial condition or cash flows.

In addition, our Convertible Notes bear interest at fixed rates of 5.75% and 3.25% for the 2023 Notes and the 2021 Notes, respectively. Therefore, we have no direct financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Notes changes primarily when the market price of our common stock fluctuates or interest rates change.

Exchange Rate Risk

We are subject to currency translation exposure on the results of our

non-U.S.

operations, primarily in the United Kingdom and Europe. Foreign currency translation risk is the risk that exchange rate gains or losses arise from translating foreign entities’ statements of earnings and balance sheets from functional currency to our reporting currency (the U.S. dollar) for consolidation purposes. The advisory fees earned on our European listed ETPs are predominantly in U.S. dollars (and also paid in gold ounces, as described below); however, expenses for corporate overhead are generally incurred in British pounds. Currently, we do not enter into derivative financial instruments aimed at offsetting certain exposures in the statement of operations or the balance sheet but may seek to do so in the future.

Exchange rate risk associated with the euro is not considered to be significant.

Commodity and Cryptocurrency Price Risk

Fluctuations in the prices of commodities and cryptocurrencies that are linked to certain of our ETPs could have a material adverse effect on our AUM and revenues. In addition, a portion of the advisory fee revenues we receive on our ETPs backed by gold, other precious metals and cryptocurrencies are paid in the underlying metal or cryptocurrency. While we readily sell the gold, precious metals and cryptocurrencies that we earn under these advisory contracts, we still may maintain a position. We currently do not enter into arrangements to hedge against fluctuations in the price of these commodities and cryptocurrencies and any hedging we may undertake in the future may not be cost-effective or sufficient to hedge against this exposure.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of June 30, 2023, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule

13a-15(b)

promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2023, our disclosure controls and procedures were effective at a reasonable assurance level in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules, regulations and forms of the SEC, including ensuring that such material information is accumulated by and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Table of Contents

Changes in Internal Control over Financial Reporting

During the quarter ended June 30, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We may be subject to reviews, inspections and investigations by the SEC, Commodity Futures Trading Commission (CFTC), National Futures Association (NFA), state and foreign regulators, as well as legal proceedings arising in the ordinary course of business. See Note 13 to our Consolidated Financial Statements for additional information regarding claims brought by investors in our WisdomTree WTI Crude Oil 3x Daily Leveraged ETP totaling approximately €15.2 million ($16.6 million).

ITEM 1A.

RISK FACTORS

You should carefully consider the information set forth in Part 1, Item1A. “Risk Factors” in our Annual Report on Form

10-K

for the fiscal year ended December 31, 2022.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent sales of Unregistered Securities

None.

Use of Proceeds

Not applicable.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table provides information with respect to purchases made by or on behalf of the Company or any “affiliated purchaser” of shares of our common stock.


	Total Number of Shares Purchased		Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
Period							(in thousands)
April 1, 2023 to April 30, 2023		26,582	$	5.86		26,582
May 1, 2023 to May 31, 2023		—	$	—		—
June 1, 2023 to June 30, 2023		—	$	—		—

Total		26,582	$	—		26,582		$ 96,436

On February 22, 2022, our Board of Directors approved an increase of $85.7 million to our share repurchase program and extended the term for three years through April 27, 2025. During the six months ended June 30, 2023, we repurchased 631,087 shares of our common stock under this program for an aggregate cost of approximately $3.5 million. As of June 30, 2023, $96.4 million remained under this program for future repurchases.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

Table of Contents

ITEM 5.

OTHER INFORMATION

10b5-1

Trading Arrangements

During

the three months ended June 30, 2023, none of our directors or officers (as defined in

Rule 16a-1(f) of

the Exchange Act) adopted, terminated or modified a Rule

10b5-1

trading arrangement or

non-Rule

10b5-1

trading arrangement (as such terms are defined in Item 408 of Regulation

S-K).

Table of Contents

ITEM 6.

EXHIBITS

EXHIBIT INDEX


Exhibit Number		Description

3.1		Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

3.2		Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Name Change) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 7, 2022)

3.3		Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Declassification of Board of Directors) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022)

3.4		Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Increase in Authorized Shares) (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022)

3.5		Certificate of Designations of Series A Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on April 13, 2018)

3.6		Certificate of Designations of Series B Junior Participating Cumulative Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 8-A filed with the SEC on March 20, 2023)

3.7		Certificate of Designations of Series C Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on May 10, 2023)

3.8		Fourth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 7, 2022)

4.1		Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

4.2		Amended and Restated Stockholders Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.2 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

4.3		Securities Purchase Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.3 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

4.4		Securities Purchase Agreement among the Registrant and certain investors dated October 15, 2009 (incorporated by reference to Exhibit 4.4 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

4.5		Third Amended and Restated Registration Rights Agreement dated October 15, 2009 (incorporated by reference to Exhibit 4.5 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)

4.6		Investor Rights Agreement, dated April 11, 2018, between the Registrant and ETFS Capital (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on April 13, 2018)

4.7		Indenture, dated as of June 16, 2020, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 17, 2020)

4.8		Form of Global Note, representing the Registrant’s 4.25% Convertible Senior Notes due 2023 (included as Exhibit A to the Indenture filed as Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 17, 2020)

4.9		Indenture, dated as of June 14, 2021, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on June 14, 2021)

4.10		Form of Global Note, representing the Registrant’s 3.25% Convertible Senior Notes due 2026 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on June 14, 2021)

4.11		Indenture, dated as of February 14, 2023, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on February 14, 2023)

4.12		Form of Global Note, representing the Registrant’s 5.75% Convertible Senior Notes due 2028 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on February 14, 2023)

Table of Contents


Exhibit Number		Description

4.13		Stockholder Rights Agreement, dated as of March 17, 2023, between the Registrant and Continental Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form 8-A filed with the SEC on March 20, 2023)

4.14		Amendment No. 1, dated as of May 4, 2023, to Stockholder Rights Agreement, dated as of March 17, 2023, between the Registrant and Continental Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 5, 2023).

4.15		Amendment No. 2, dated as of May 10, 2023, to Stockholder Rights Agreement, dated as of March 17, 2023, between the Registrant and Continental Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on May 10, 2023)

4.16		Investor Rights Agreement, dated as of May 10, 2023, by and between the Registrant and Gold Bullion Holdings (Jersey) Limited (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on May 10, 2023)

10.1		Sale, Purchase and Assignment Deed, dated as of May 10, 2023, by and between the Registrant, WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital Limited, World Gold Council, Gold Bullion Holdings (Jersey) Limited, Rodber Investments Limited and Graham Tuckwell (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on May 10, 2023)

10.2		Amendment to Employment Agreement between the Registrant and Alexis Marinof, dated April 21, 2023 (incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on May 9, 2023)

10.3		Form of Amendment, dated April 21, 2023, to Employment Agreements between the Registrant and each of Jonathan Steinberg, Peter M. Ziemba, R. Jarrett Lilien and Marci Frankenthaler (incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on May 9, 2023)

10.4		WisdomTree, Inc. Executive Severance Plan (incorporated by reference to Exhibit 10.3 of the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on May 9, 2023)

10.5		Form of Employee Confidentiality, Assignment and Restrictive Covenant Agreement executed by participants of the WisdomTree, Inc. Executive Severance Plan (incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on May 9, 2023)

31.1 (1)		Rule 13a-14(a) / 15d-14(a) Certification

31.2 (1)		Rule 13a-14(a) / 15d-14(a) Certification

32.1 (2)		Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101 (1)		Financial Statements from the Quarterly Report on Form 10-Q of the Company for the three months ended June 30, 2023, formatted in XBRL: (i) Consolidated Balance Sheets at June 30, 2023 (Unaudited) and December 31, 2022; (ii) Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three and six months ended June 30, 2023 and June 30, 2022 (Unaudited); (iii) Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2023 and June 30, 2022 (Unaudited) (iv) Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and June 30, 2022 (Unaudited); and (v) Notes to Consolidated Financial Statements, as blocks of text and in detail.

101.SCH (1)		Inline XBRL Taxonomy Extension Schema Document

101.CAL (1)		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF (1)		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB (1)		Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE (1)		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 (1)		Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)

(1)

Filed herewith.

(2)

Furnished herewith.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 4

day of August 2023.


WISDOMTREE, INC.

By:		/s/ Jonathan Steinberg
		Jonathan Steinberg
		Chief Executive Officer (Principal Executive Officer)

WISDOMTREE, INC.

By:		/s/ Bryan Edmiston
		Bryan Edmiston
		Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

Stock options:

Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.

RSAs/RSUs:

Awards are valued based on the Company’s stock price on grant date and generally vest ratably, on an annual basis, over three years.

These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.